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ABSTRACT

Meiosis is the process that ensures the continued propagation of new organisms and is
a source of genetic variability within a population. During meiotic prophase many
dynamic rearrangements occur in the nucleus of the cell. These rearrangements include
homologous chromosome pairing, recombination, synaptonemal complex breakdown,
chromosome condensation and spindle assembly. The regulatory mechanisms behind
these complex processes at the G2/MI transition have not been completely elucidated,
preventing our complete understanding of the processes. The purpose of this work is to
provide new insight to the events and players involved in the regulation of the G2/MI
transition in mouse spermatocytes.
Part I will provide an overview of meiosis, focusing in particular on how little is
known of the kinases regulating the first meiotic division of spermatogenesis. As a way
to fill the gaps in our knowledge about what events occur, in what order they occur, and
how they may be interrelated we used antibodies against various proteins involved in
chromosome pairing, recombination, spindle assembly, and those that mediate the cell
cycle and followed their localization by immunofluorescence. These results are presented
in Part II and provide a framework for which both mechanisms of normal meiosis as well
as mutant phenotypes can be monitored.
Part III focuses on elucidation of the participants involved in regulation of the first
meiotic division in spermatogenesis, with particular attention given to the mitogenactivated protein kinases (MAPKs). Chemical inhibitors and mutant genetic mouse
models were used to investigate the pathway leading to the activation of the MAPKs and
v

their role in the G2/MI transition. The results suggest that spermatocytes may have a
novel mechanism for MAPK activation and that this regulation may depend, directly or
indirectly, on maturation promoting factor (MPF).
In Part IV the findings of collaborative projects with other laboratories analyzing the
expression of chromosomal proteins and the characterization of meiotic mutants is
discussed. These studies provide new information as to the players and their roles in
sister chromatid cohesion (REC8, RAD21, SMC1, SMC1β, SMC3), recombination
(mei1) and chromatin remodeling (H1a, H1t) during spermatogenesis.
Overall the findings reported in this dissertation will aid in our understanding of the
meiotic G2/MI transition in mouse spermatocytes. Specifically in the final part of this
dissertation, Part V, the landmarks of meiotic prophase and the players regulating the
transition in males will be compared to those known to regulate the meiotic divisions in
the female. These findings will shed new light onto the sexual dimorphisms that exist
between the male and female meiotic divisions, but more importantly on the regulatory
molecules involved at the G2/MI transition.
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PART I

INTRODUCTION
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CHAPTER I
MEIOSIS: AN OVERVIEW

Meiosis is a unique cell division process that occurs only in the precursors to the
gametes, or spores of sexually reproducing organisms. During meiosis, the chromosome
number of a diploid cell is reduced in half, generating haploid gametes that have a single
member of each chromosome pair. The focus of this dissertation will be on meiosis in
higher eukaryotes, particularly mammals, where it is an integral part of the reproductive
process.
Meiosis is initiated with a single round of DNA replication, which is followed by an
extended prophase and two successive division phases. During meiotic prophase I
homologous chromosomes pair, synapse and recombine. The sites of reciprocal
crossovers are essential for maintaining homologous chromosome pairing through the
first meiotic division and ensuring proper segregation (for review see Hawley, 1988;
Carpenter, 1994). Errors in the meiotic division phases can occur and result in the
production of aneuploid gametes, sperm or eggs that have an extra copy of a chromosome
or a deficiency in chromosome number. The consequences of meiotic non-disjunction
are severe, and most often lethal, making it the leading genetic cause of pregnancy loss
(for review see Hassold and Hunt, 2001). Two of the most common aneuploid conditions
compatible with survival are Down syndrome (trisomy, or Ts,#21) and Kleinfelter
syndrome (XXY). Given the severity of the consequences of meiotic error, it is
important to understand both the events and players regulating this cell division process.
The experiments reported in this dissertation made use of mouse spermatocytes as a
2

model to elucidate the temporal ordering of events and the cell cycle proteins necessary
for transition out of meiotic prophase I into the division phase during spermatogenesis.
These experiments will aid in our overall understanding of the meiotic cell divisions and
further our knowledge about the sexual dimorphism that exists in the regulation of male
and female meiosis.

Males and Females Initiate Meiosis at Different Developmental Times
The overall goal of meiotic division is to produce haploid gametes, however,
differences exist in the timing and approach taken by males and females to reach this
goal. One of the most obvious differences is in the time in which meiosis is initiated in
each sex.
The germ cell lineage in both male and female mice is established at the time of early
gastrulation, approximately 7 days post coitum (dpc), when an estimated 40 primordial
germ cells migrate from the fetal extra-embryonic membranes to the site of the
developing gonads (Lawson and Hage, 1994). By 10.5 dpc the germ cells have colonized
the developing genital ridges and start to undergo a series of mitotic divisions. These
divisions continue until 13.5 dpc when mitotic proliferation ceases in both sexes.
However, in the female meiosis is immediately initiated in a few cells, followed soon
thereafter by the entire population (McLaren, 1983). It is estimated that by 14 dpc the
female primordial germ cells can give rise to 20,000-25,000 oocytes (Mintz and Russell,
1957; Tam and Snow, 1981).
In contrast to this pattern, male germ cells do not enter into meiosis until the onset of
puberty. At approximately 4 days post-partum the germ cells present in the testis
3

differentiate into spermatogonia. The spermatogonia, otherwise known as type As
spermatogonia, are self-renewing and start to undergo mitotic divisions at post-natal day
7. These mitotic divisions serve a two-fold purpose, to renew the stem cell population of
the testis and to give rise to type A1 spermatogonia that are destined to enter meiosis,
after a set number of mitotic divisions and differentiation (for review see Meistrich and
van Beek, 1993).

Meiosis I Prophase: An Extended Phase
1. Overview
Many of the events that define meiosis occur during the extended prophase that
precedes the first division. Both oocytes and spermatocytes take approximately one week
to progress through this stage. Although spermatocytes and oocytes spend an equivalent
amount of time in prophase I, the fetal oocytes are not amenable to experimental analysis
at this stage. Also, fetal oocytes progress through the first few sub-stages of prophase
before birth and then arrest in an extended dictyate phase, a distinct difference from the
pace of meiotic progress in spermatocytes. Since meiosis is not initiated until puberty in
the male, almost all sub-stages of meiotic prophase are readily obtainable by cell
separation techniques (Bellvé, 1993) or can be readily identifiable by cytological
methods. These features underlie the fact that most of our knowledge about mammalian
meiotic prophase derives from studies of spermatocytes.
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2. Chromosome Synapsis
One of the defining characteristics of meiotic prophase that has been extensively
studied by cytology is the intimate associations that form between homologous
chromosomes (for review see Moens et al., 1998). The proteinaceous structure that is
responsible for maintaining this intimate association is the synaptonemal complex. The
synaptonemal complex is a tripartite structure composed of two lateral elements, which
are referred to as the axial elements before synapsis of the homologous chromosomes,
and a central element. During leptonema, the axial elements of the synaptonemal
complex begin to form along each chromatid pair. As spermatocytes progress into
zygonema the homologous chromosomes begin to align and become closely apposed at
several sites. Complete synapsis of the homologous chromosomes defines pachynema,
when the mature synaptonemal complex extends the entire length of the homologous
chromosomes. When the spermatocyte reaches diplonema, the homologous
chromosomes begin desynapsis and subsequent disassembly of the synaptonemal
complex occurs in preparation for the first meiotic division and segregation of
homologous chromosomes.

3. Recombination
In conjunction with the formation of the synaptonemal complex, meiotic
recombination occurs. Recombination not only ensures genetic variation among the
products of meiosis, but is also essential in maintaining proper pairing and segregation of
the homologous chromosomes at the first meiotic division. Without the chiasmata that
result from reciprocal crossovers, homologous chromosome pairing would not be
5

maintained after breakdown of the synaptonemal complex at diplonema, resulting in
random segregation of the chromosomes at MI, leading to the production of aneuploid
gametes (Hawley, 1988). Therefore, at least one reciprocal exchange is needed per
homologous chromosome pair to maintain pairing and for proper alignment on the
metaphase spindle (Carpenter, 1984).
Recombination is initiated during leptonema by the formation of DNA double-strand
breaks. The meiosis specific topoisomerase II-like protein, SPO11, has been shown to be
responsible for creation of double-strand breaks in several eukaryotic systems, including
mice and humans (for review see Keeney, 2001; Baudat et al., 2000; Romanienko and
Camerini-Otero, 2000). The double-strand breaks are resected to produce 3’ singlestranded overhangs capable of undergoing homology searches (Sun et al., 1991; Zenvirth
et al., 2003). The 3’overhangs associate with the RecA-like enzymes, DMC1 and
RAD51, catalyzing strand exchange to form Holliday junctions that are resolved as
recombinant molecules. Evidence of the genetic exchanges becomes apparent during
diplonema when chiasmata, the visible manifestations of recombination, are observed.
The chiasmata are then resolved at MI allowing for the proper segregation of homologous
chromosomes.
Although recombination occurs in both male and female gametocytes, numerous
reports have documented higher recombination frequencies in females (for review see
Pittman and Schimenti, 1998). It has been suggested that crossing over may occur at
preferred regions of the genome and that these differ between the sexes, explaining the
difference in recombination frequencies (Polani, 1972; Speed, 1977). More recently
newly developed immunofluorescence methods have implicated total length of the
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synaptonemal complex as a factor in contributing to the differences in recombination
frequency between the sexes (Lynn et al., 2002).
Analysis of mammalian recombination and the molecules involved has been difficult
and almost impossible in some instances, complicating explanation of the observed
sexual dimorphisms. Most of the earliest information on meiosis and recombination
derived from studies of the yeast Saccharomyces cerevisiae. These studies identified
genes as potential candidates for function during mammalian meiosis, but mutational
analysis of individual genes was, until recently, not possible as in yeast. Over the last
decade advances in knockout technology have enabled researchers to investigate
recombination processes in mammals on a gene-by-gene basis by analysis of the mutant
phenotypes. These investigations have provided insight into the regulation and players of
mammalian recombination and homologous chromosome pairing, and have identified
regulators that are essential to both sexes and those that produce sexual dimorphic mutant
phenotypes.

4. Gene Mutations Affecting Meiotic Prophase with Sexual Dimorphic Phenotypes:
Spo11, Scp3, and H2ax
Knockout technology has been used to generate mutations in genes thought to be
essential for homologous chromosome pairing/synapsis, recombination, and DNA
replication/repair. These genes include Atm, Atr, Rad51, Dmc1, Msh4, Msh5, Mlh1,
Pms2, H2ax, Spo11, Scp3 and Mlh3 (for review see Cooke and Saunders, 2002; Matzuk
and Lamb, 2002). Generation of both Atr and Rad51 mutant mice resulted in embryonic
lethality. These studies demonstrated the necessity of these proteins during development,
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but prevented analysis of their roles, if any, in meiosis (Lim and Hasty, 1996; Brown and
Baltimore, 2000; de Klein et al., 2000). As opposed to the embryonic lethality observed
in Atr and Rad51-deficient mice, mutations in other genes involved in recombination and
homologous pairing have provided valuable information as to the players involved in
regulation of these processes, but surprisingly have also revealed sexual dimorphisms that
exist in these processes between males and females. This is particularly true for
mutations in the Spo11, Scp3, and H2ax genes.
Generation of Spo11-deficient mice resulted in both male and female infertility.
However, spermatocytes arrest early in meiotic prophase, before pachynema, while
oocytes arrest much later in prophase at diplonema. Mutant gametocytes displayed
homologous chromosome synapsis defects and the RecA-like enzymes, RAD51 and
DMC1, failed to localize on meiotic chromosome spreads, indicating the absence of DNA
double-strand breaks (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000).
Generation and analysis of the Spo11 mutants demonstrated both a requirement for DNA
double-strand breaks in the initiation of meiotic recombination, and that SPO11 is the
enzyme responsible for the generation of these breaks in mammals. Perhaps more
interestingly, the Spo11 knockout mice demonstrated the necessity of recombination for
homologous chromosome pairing/synapsis. In the absence of Spo11, axial element
formation occurred, however, mature synaptonemal complexes were never observed,
providing insight into the temporal ordering of events during mammalian meiosis
(Baudat et al., 2000; Romanienko and Camerini-Otero, 2000; Mahadevaiah et al., 2001).
Creation of Scp3 knockout mice also revealed sexual dimorphism in requirements for
progression through prophase. SCP3 is a major component of the axial/lateral elements
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of the synaptonemal complex, responsible for the maintenance of homologous
chromosome pairing. In the absence of SCP3, spermatocytes arrest in a zygotene-like
state, and fail to form lateral/axial elements, leading to male infertility (Yuan et al.,
2000). The lateral/axial elements have been shown to be necessary for both the
stabilization of recombination-related protein complexes on meiotic chromosome cores,
and for the completion of homologous chromosome synapsis in spermatocytes. An
underlying cohesion core has been shown to be responsible for initiating the intimate
contacts found between homologous chromosomes during meiotic prophase (Pelttari et
al., 2001).
Unlike Scp3-deficient males, females deficient in Scp3 are fertile, but produce smaller
litter sizes than their wild-type offspring. Reduction in litter size was found to increase
with maternal age and has been attributed to aneuploidy as a result of improper chiasmata
formation, which affects subsequent segregation of homologous chromosomes at MI
(Yuan et al., 2002).
Mutation of histone H2ax also resulted in sexually dimorphic meiotic phenotypes
(Celeste et al., 2002). Histone H2AX, a highly conserved histone H2A subtype, contains
a phosphatidyl inositol 3-kinase motif that is phosphorylated in response to DNA doublestrand breaks (for review see Redon et al., 2002; Rogakou et al., 1998). This
phosphorylation is thought to recruit repair factors, such as BRCA1, BRCA2 and
RAD51, to the sites of damaged DNA (Paull et al., 2000). Male mice lacking H2ax are
infertile as a result of primary spermatocyte arrest at the zygotene-stage of meiotic
prophase. A few spermatocytes progress to the early pachytene stage, but typically
exhibit characteristics of apoptosis. The sex chromosomes also fail to synapse or are
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highly fragmented in mutant spermatocytes. Additionally abnormalities in the
localization pattern of MLH1, a mismatch-repair protein known to be associated with late
recombination nodules, was observed, suggesting defects in the repair of double-strand
breaks initiated during recombination. In contrast to the phenotype observed in H2axdeficient males, females deficient for H2ax are fertile, although litter size is reduced
compared to either wild-type or heterozygous females (Celeste et al., 2002). Thus again,
in females, oocytes “squeak through” in the face of deficiencies that lead to spermatocyte
failure.

5. Evidence for a DNA Damage Independent Checkpoint in Spermatocytes
Mutations of genes in the mouse with predicted function in DNA replication/repair,
recombination or homologous chromosome pairing have yielded insight into the temporal
order of events during mammalian meiotic prophase. Generation and analysis of the
Spo11 and Scp3 mutants suggest that during mammalian meiosis recombination is needed
to initiate homologous chromosome synapsis, similar to observations in the yeast S.
cerevisiae (Padmore et al., 1991; Roeder, 1997; Zickler and Kleckner, 1998). In the
absence of double-strand breaks, homologous chromosome synapsis does not occur,
which suggests that formation and processing of recombination intermediates are
required for promoting synapsis (Baudat et al., 2000; Romanienko and Camerini-Otero,
2000), an idea supported by the observation that DNA strand breaks induced by treatment
with cisplatin lead to partial synapsis in Spo11-/- mutants (Romanienko and CameriniOtero, 2000). Likewise, recombination is not dependent upon synapsis. In the absence
of the synaptonemal complex, double-strand breaks are generated and repair proteins are
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recruited to the sites of DNA damage, suggesting that at least initiation of recombination
can occur without homologous chromosome associations mediated by the axial elements
of the synaptonemal complex (Yuan et al., 2000).
Analysis of mutants also revealed sexual dimorphism in the regulation of events and
checkpoints during meiotic prophase. Spermatocytes from mouse models deficient in the
mismatch repair proteins Dmc1, Msh4, and Msh5 have been shown to arrest early in
meiotic prophase, leading to apoptosis (Pittman et al., 1998; Yoshida et al., 1998; de
Vries et al., 1999; Edelmann et al., 1999; Kneitz et al., 2000). This arrest and subsequent
death has been attributed to unrepaired DNA damage. However, the arrest of Spo11deficient spermatocytes in early meiotic prophase, in the absence of DNA double-strand
breaks, is suggestive of a DNA damage independent checkpoint in the male. It has been
suggested that such a checkpoint exists and can monitor chromosome structure and
synapsis, such as formation of the synaptonemal complex (Miklos, 1974; Burgoyne and
Baker, 1985; Odorisio et al., 1998). However, analysis of oocytes from Spo11 and Scp3deficient mice indicate that females may not have a DNA damage independent
checkpoint or that this checkpoint is less stringent than the one found in males, thereby
allowing further progression through prophase or even progression through the division
phase (Burgoyne and Baker, 1985; Odorisio et al., 1998).

Further phenotypic analysis

of H2ax-deficient females may also provide additional insight into these checkpoints and
their regulation in oocytes.
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Meiosis I Division Phase: Setting Up Reductional Segregation
1. Overview
After an extended period in meiotic prophase, the gametocytes undergo the first
meiotic division. Spermatocytes enter into the division phase immediately following
completion of prophase, whereas oocytes enter the division after a lengthy arrest at the
dictyate stage of late prophase.
The primary objective of the first meiotic division is to reduce the chromosomal
number of the gametocytes by half. The homologous chromosomes, which have
previously recombined and are held together by their chiasmata, align on the metaphase I
spindle and are randomly segregated to opposite poles of the cell. This reductional
division is unique, and unlike the second meiotic division, which is equational and more
mitotic-like in nature. In males, the second meiotic division, in which the sister
chromatids are separated, immediately follows the first division, resulting in the
production of four haploid round spermatids that will develop into function spermatozoa.
However, unlike spermatocytes, oocytes arrest after the first meiotic division and will
complete the second division when fertilization occurs. Also while each primary
spermatocyte produces four haploid spermatids, the female meiotic division is an unequal
division, producing only a single egg from a primary oocyte.
Many dynamic rearrangements occur in the nucleus of the gametocyte prior to the
meiotic divisions. However, very little is known of what is required by the gametocytes
for progression from prophase to the division phase and if the regulators and processes
are conserved. Due to the difficulty of obtaining spermatocytes naturally undergoing the
division phase, much more is known of the players required for progression from the late
12

dictyate arrest in oocytes than of the regulators involved in this transition in
spermatocytes.

2. Regulation of the G2/MI Transition in Oocytes
Once an oocyte arrests in the dictyate stage of late prophase, it is not yet capable of
undergoing the first meiotic division (Szybek, 1972; Erickson and Sorensen, 1974;
Sorensen and Wassarman, 1976; Wickramasinghe et al., 1991). This arrest is in part due
to the somatic companion cells surrounding the oocyte, but is also due to the autonomous
regulatory mechanisms of the oocyte (for review see Handel and Eppig, 1998).
Maturation promoting factor (MPF), produced autonomously by the oocyte, is one factor
necessary for the transition out of meiotic prophase arrest (Hashimoto and Kishimoto,
1988; Chesnel and Eppig, 1995). MPF is a heterodimer composed of two subunits, a
regulatory CYCLIN B1 subunit and a catalytic serine/threonine kinase subunit referred to
as p34cdc2 (CDC2), which are produced at various times in the arrested oocyte. CYCLIN
B1 levels peak in oocytes that are not yet competent to resume meiosis, while levels of
CDC2 continually increase as the oocyte grows and gains competency to undergo
germinal vesicle breakdown (Chesnel and Eppig, 1995; de Vantery et al., 1996; Mitra
and Schultz, 1996; Kanatsu-Shinohara et al., 2000). The observed increase in expression
levels of CDC2 as the oocyte gains competence correlates well with the activation status
of MPF, which has been shown to increase steadily from before germinal vesicle
breakdown to the first meiotic division (Hashimoto and Kishimoto, 1988; Choi et al.,
1991; Hampl and Eppig, 1994).
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Although synthesis of CYCLIN B1 and CDC2 have been shown to be essential for
meiotic progression, studies have demonstrated that production of these components
alone is not sufficient for the resumption of meiosis (Chesnel et al., 1994). However,
treatment with okadaic acid (OA), a type 1 and 2A phosphatase inhibitor, activates MPF,
thereby stimulating germinal vesicle breakdown in otherwise incompetent oocytes,
suggesting that other regulatory molecules are involved in regulating the activation state
of MPF (Chesnel et al., 1994; Chesnel and Eppig, 1995). The CDC25C protein
phosphatase has been shown to be a direct regulator of MPF. CDC25C acts by removing
the inhibitory phosphates from threonine 14 and tyrosine 15 residues on CDC2 (Gautier
et al., 1991; Kumagai and Dunphy, 1991; Strausfeld et al., 1991). As the oocyte acquires
competence, levels of CDC25C increase while those of the inhibitory tyrosine kinase
WEE1, responsible for the phosphorylation and inactivation of CDC2, decrease,
indicating that increasing levels of CDC25C also correlate with increasing competence
(Mitra and Schultz, 1996; Kanatsu-Shinohara et al., 2000). However, recent reports
suggest that CDC25B may be necessary for meiotic resumption, instead of the CDC25C
protein phosphatase in oocytes. Female mice deficient for Cdc25C are fertile with no
obvious phenotype (Chen et al., 2001), while females lacking Cdc25B arrest at meiotic
prophase I with low levels of MPF activity (Lincoln et al., 2002). This arrest can be
overcome by injection of Cdc25B mRNA into Cdc25B- deficient oocytes, further
suggesting that CDC25B, and not CDC25C, is required for acquisition of meiotic
competence and activation of MPF in mouse oocytes (Lincoln et al., 2002).
MPF activity is needed not only during the transition from meiotic prophase arrest, but
is also likely to be a requirement for maintaining metaphase II (MII) arrest. Cytostatic
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factor (CSF) is the multi-component complex that is responsible for sustaining MPF
activity needed for arrest at MII (Masui and Markert, 1971; Haccard et al., 1993; Abrieu
et al., 2001; Gordo et al., 2001; Ohashi et al., 2003). CSF activity is generally
considered to be the coordinated action of the MOS protein and the mitogen-activated
protein kinases (MAPKs) (Matsuda et al., 1992; Haccard et al., 1993; Verlhac et al.,
1993; Abrieu et al., 2001). However, more recent data suggests that the mitogenactivated protein kinase kinase, MEK, should also be included as an integral component
of CSF in mouse oocytes (Phillips et al., 2002). CSF is thought to maintain the high
levels of MPF activity required for arrest by preventing the destruction of the regulatory
CYCLIN B1 subunit (Kubiak et al., 1993)
The question as to whether CSF is responsible for maintaining MPF activity levels in
mammals is still a subject of controversy. A recent report by Josefsberg et al. (2003)
suggests that MPF may control the activation of the MAPKs through the stabilization of
Mos mRNA in rat oocytes. Phenotypic analysis of Mos-deficient mice also lends support
to this hypothesis. Oocytes that lack the MOS protein fail to arrest at MII and
subsequently fail to activate the MAPKs (Colledge et al., 1994; Hashimoto et al., 1994).
More importantly, MPF is active in the Mos-deficient oocytes, suggesting that CSF is at
least not involved in the activation of MPF (Verlhac et al., 1996).
In addition to playing an important role in maintaining MII arrest, the MAPKs have
also been implicated in germinal vesicle breakdown and in the exit from meiotic
prophase arrest in porcine oocytes (Inoue et al., 1998). However, the MAPKs are not
activated until after germinal vesicle breakdown in mouse oocytes, suggesting they are
not necessary for the resumption of meiosis. However, they have been shown to be
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required for post germinal vesicle breakdown events such as in spindle formation
(Sobajima et al., 1993; Verlhac et al., 1993; Lu et al., 2002). A similar regulation has
also been reported in bovine oocytes (Gordo et al., 2001).

3. Regulation of the G2/MI Transition in Spermatocytes
The G2/MI transition is much more difficult to study in spermatocytes, partially
because there is no arrest in late prophase as in oocytes, thereby preventing accumulation
of cells at the G2/MI transition. Further complicating analysis is the short division phase
in spermatocytes, only two days or less being needed for progression from diplonema
through both the first and second meiotic divisions. Since the divisions are quick, the
dividing spermatocytes are greatly outnumbered by both the pre-meiotic and post-meiotic
cells of the testis (Handel and Eppig, 1998). Additionally, MI spermatocytes have no
defining characteristics that allow for their separation by conventional methods (Bellvé et
al., 1993). Therefore, much of what is known about the G2/MI transition in
spermatocytes has come from in vitro studies using pachytene spermatocytes in a shortterm culture system (Handel et al., 1995).
Isolated pachytene spermatocytes do not naturally undergo the G2/MI transition when
cultured. However, upon treatment with OA, pachytene spermatocytes undergo a
precocious G2/MI transition, characterized by condensation of chiasmate bivalent
chromosomes and disassembly of the synaptonemal complex. The condensed
chromosomes observed following OA treatment are morphologically indistinguishable
from those that undergo the natural transition to metaphase I, suggesting that the OAinduced transition mimics the naturally occurring transition (Wiltshire et al., 1995).
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Additionally, an increase in H1 kinase activity is also observed after treatment with OA,
suggesting that as in oocytes, MPF may regulate the G2/MI transition during
spermatogenesis (Wiltshire et al., 1995).
Although during oogenesis the expression of CDC2 increases as the oocyte acquires
developmental competence, this does not seem to be the case during spermatogenesis.
CDC2 and CYCLIN B1 are both expressed in leptotene and zygotene spermatocytes, but
both cell types are incompetent and are unable to undergo the precocious G2/MI
transition induced by OA. Although leptotene and zygotene spermatocytes possess both
components of MPF they demonstrate no H1 kinase activity, suggesting that MPF is not
active in early prophase spermatocytes (Cobb et al., 1999a). A possible explanation for
this observation is that CDC25C, the phosphatase responsible for MPF activation, is not
expressed until mid-pachynema, which is the same time spermatocytes demonstrate
competence to undergo the transition from prophase to the first division phase (Cobb et
al., 1999a). However, mice deficient for Cdc25C are fertile and have no visible
phenotype, suggesting that CDC25C is not needed for the G2/MI transition or for
spermatogenesis and that another regulatory molecule regulates MPF activation during
male meiosis (Chen et al., 2001).
Although the role of CDC25C has recently been called into question, other studies
have demonstrated the necessity of MPF in the regulation of the spermatocyte’s G2/MI
transition. Treatment of pachytene spermatocytes with the CDC2 inhibitor, butyrolactone
I, resulted in inhibition of OA-induced chromosome condensation, suggesting that MPF
is essential for the precocious transition induced by OA (Cobb et al., 1999b). However,
not all aspects of chromosome condensation were inhibited in response to butyrolactone I
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treatment. Phosphorylation of histone H3 still occurred, so although MPF is involved in
regulating chromosome condensation, it is not the only molecule involved in
spermatocytes (Cobb et al., 1999b).
MPF appears to be important for the G2/MI transition in both males and females, but
given the sexual dimorphism that exist in other aspects of meiosis it also seems feasible
that differences may exist in the regulation of the gametocytes from meiotic prophase to
the division phase. The first reports to document such a difference in the regulatory
molecules needed for this transition in males and females investigated the MOS protein.
MOS, the mitogen-activated protein kinase kinase kinase necessary for the arrest of
oocytes at MII, does not seem to be required for spermatogenesis. Analysis of male mice
deficient for Mos showed no impairment of spermatogenesis, and males are fertile.
However, this is in contrast to the sterility observed in female mice deficient for Mos,
suggesting that although males and females may share some common regulatory
molecules not all the players are conserved (Colledge et al., 1994; Hashimoto et al.,
1994).
Although MOS is not needed during spermatogenesis, its downstream targets, the
MAPKs, have been implicated in regulating aspects of chromosome condensation during
the G2/MI transition. Treatment with either of the MEK1/2 inhibitors, PD98059 or
U0126, was reported to prevent the OA-induced chromosome condensation of pachytene
spermatocytes (Sette et al., 1999; Di Agostino et al., 2002). Further analysis of the
MAPKS involvement in chromosome condensation suggests that their activation leads to
the phosphorylation/activation of p90rsk2, which subsequently activates the NIMA-related
kinase 2, NEK2, leading to chromosome condensation (Di Agostino et al., 2002).
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The regulation of chromosome condensation by the MAPK pathway is one of the few
regulatory pathways shown to act during the G2/MI transition during spermatogenesis.
Much of what is about this transition has been inferred from studies using oocytes or
expression analysis, few reports have demonstrated the direct action of regulatory
molecules during the G2/MI transition during spermatogenesis and those that have had
exhibited sexual dimorphism (i.e. MOS, CDC25B). Therefore more studies are needed to
determine the regulatory molecules involved in the transition so that meiosis and the
sexual dimorphism that exists can be better understand.

Conclusion
Unfortunately, we still know very little about the factors governing transition from
meiotic prophase to the division phase in spermatocytes, largely due to their short
division time and lack of distinguishing characteristics that would allow for their
separation, making analysis difficult. However, this has been overcome in part by the
development of a short-term culture system utilizing the phosphatase inhibitor OA. The
advancement of knockout technology and the synthesis of new chemical inhibitors have
also advanced our understanding of the G2/MI transition during spermatogenesis.
However, there remain gaps in our knowledge. Therefore the focus of this dissertation is
to elucidate further the temporal ordering of events and the regulatory molecules required
for the G2/MI transition in mouse spermatocytes. More specifically, Part II of this
dissertation focuses on determining the temporal order of events during male meiosis.
This was accomplished by using indirect immunofluorescence localization of antibodies
against proteins involved in homologous chromosome pairing, recombination, as well as
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those that mediate cell cycle progression. The creation of the “timeline” helps us to
determine what events occur, in what order they occur, and how they may be interrelated.
Additionally, these results provide a framework for which we can monitor meiosis in
mutant mice.
Part III focuses on elucidating players involved in the transition from meiotic
prophase to the division phase with particular attention given to the MAPKs. Previous
studies have demonstrated the role of the MAPKs in regulating the G2/MI transition in
oocytes, however, virtually nothing is known of their regulation and role, if any, in
spermatogenesis. Both chemical inhibitors and mutant mouse models were used to
determine their function and importance at this transition in the male. The results suggest
that spermatocytes may have a novel regulatory mechanism for MAPK activation that
does not require MOS or MEK1/2.
Finally in Part IV we investigate the expression of proteins thought to be involved in
maintaining sister chromatid cohesion (REC8, RAD21, SMC1, SMC3, SMC1β) as well
as characterizing new mutant mouse models (mei1 and H1a, H1t). These studies provide
insight into the roles of specific genes/protein during spermatogenesis, enhancing our
overall knowledge of the process.
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PART II

TEMPORAL ORDERING OF EVENTS DURING MALE GERM CELL
MEIOTIC PROPHASE AND THE DIVISION PHASE*

*The work for this part was accomplished by efforts of Amy Inselman and Shannon
Eaker.
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ABSTRACT

During spermatogenesis, the complex events of the first meiotic prophase and division
phase bring about dramatic changes in nuclear organization. One factor frustrating
mechanistic dissection of these events is lack of knowledge about precisely what events
occur, in what order they occur, and how they may be interrelated by temporal sequence;
in other words, a precise “timeline” is lacking. This problem was tackled by following
expression, using Western blotting and immunolocalization in mouse spermatocytes, of
proteins critical to events of the meiotic cell division process. We assayed for proteins
that are primarily chromosomal (modified histones and recombination-related proteins),
those that form structural elements for chromosomal dynamics (a synaptonemal complex
protein, tubulins and pericentrins) and mediators of the cell cycle and its checkpoints
(kinases and kinetochore proteins). Distinct and protein-specific patterns were found
with respect to expression and localization throughout meiotic prophase and division.
This information provides a foundation for a meiotic timeline that can be augmented to
provide, eventually, a complete catalog of meiotic events and their temporal sequence.
Such a framework can clarify mechanisms of normal meiosis as well as mutant
phenotypes and aberrations of the meiotic process that lead to aneuploidy.
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CHAPTER I
INTRODUCTION

Meiosis – both the recombination events of the extended meiotic prophase and the
precise reductional and equational segregations of chromosomes during the division
phase – is a defining event of gametogenesis. Surprisingly little is known about the onset
and regulation of meiotic processes in spermatogenesis, in spite of the fact that meiosis
comprises a significant portion of spermatogenic differentiation and determines the
genetic fidelity of the mature gamete. A major task in unraveling any developmental
mechanism, such as meiosis, is to establish the precise timing and order of how and when
cellular events unfold. This is especially important not only because many biological
processes are initiated by the completion of a previous process, but also because finding
the right proteins in the right places at the right time can lead to testable hypotheses about
mechanisms.
Much is already known about temporal patterns of expression and localization of
recombination-related proteins during meiotic prophase (Ashley and Plug, 1998; Cohen
and Pollard, 2001; Tarsounas and Moens, 2001). The acquisition of these data has been
facilitated by the foundation of knowledge about meiotic recombination in yeast. This
knowledge coupled with informative immunolocalization in mammalian spermatocytes
does indeed lead to mechanistic models of chromosome pairing, synapsis and
recombination (Moens et al., 2002). Likewise, the existence of a number of genetic
models with targeted interruption of genes responsible for proteins involved in synapsis
and recombination has provided useful as well as surprising information. For example,
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deficiency for key proteins in the recombination pathway, such as DMC1 and MLH1,
lead to sterility. But, surprisingly, deletion of some proteins previously thought to be
essential for chromosome pairing, such as SYCP3, leads to sexually dimorphic effects,
infertility in males, but not females, revealing unsuspected complexity in meiotic
requirements and/or meiotic checkpoints (Cohen and Pollard, 2001).
In spite of considerable knowledge about the proteins required for progress through
spermatogenic meiotic prophase, very little is known about how the division phase is
regulated or how the tempo of meiosis during spermatogenesis is determined. A key
question is how does the spermatocyte “know” that meiotic recombination is complete
and that it is “time” for the meiotic divisions – in other words, what signals the end of
meiotic prophase and the onset of the division phase? Getting this timing right is
essential, for the penalty of division before completion of recombination and
establishment of chromosomal competence for accurate segregation is gametic
aneuploidy (Koehler et al., 1996; Hassold and Hunt, 2001). It is known that metaphase
condensation of chromosome bivalents can be prompted prematurely by treatment of
spermatocytes with okadaic acid (OA), a phosphatase inhibitor (Wiltshire et al., 1995)
and that the OA-induced G2/MI transition is accompanied by many normal events,
including individualization of chiasmate bivalents (Wiltshire et al., 1995),
phosphorylation of histone H3 (Cobb et al., 1999b), disassembly of the synaptonemal
complex (Wiltshire et al., 1995; Tarsounas et al., 1999), and breakdown of the nuclear
envelope (von Glasenapp and Benavente, 2000). Spermatocytes acquire competence for
OA-induced chromosome condensation by mid-prophase at about the time that histone
H1t becomes associated with chromatin (Cobb et al., 1999a). Nonetheless, this system
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has not allowed for testing of spermatocyte competence for chromosome segregation and
evidence from injection of spermatocytes into maturing mouse oocytes suggests that midprophase spermatocytes have reduced competence for normal chromosome segregation
(Kimura et al., 1998). These observations reflect how little is known of the cytoplasmic
and nuclear biomolecular machinery that is required for the spermatocyte’s meiotic
prophase-division phase transition and how it is normally activated.
Determination of the time and order of events is an important first step to learn more
about the spermatocyte’s meiotic “cell cycle” mechanisms. An initial approximation of
event order can derive from determining temporal patterns of protein expression, both by
Western blotting and by immunofluorescent localization of proteins implicated in
progress of meiotic prophase and division phases. Analysis of protein localization with
specific antibodies can be coupled with morphological landmarks, by using microdissected specific stages of the seminiferous epithelium, and also with co-localization of
proteins previously demonstrated to be involved in events of meiotic recombination
(Cohen and Pollard, 2001). Analysis of specific mutations can also refine temporal
ordering of events as well as reveal critical checkpoints in the processes leading to the
meiotic divisions. Studies of this nature reveal that progress from meiotic prophase (G2)
to metaphase I (MI) of the division phase, the “G2/MI” transition, is a dynamic process,
involving both accumulation and relocalization of structural as well as catalytic proteins.
Both temporal order of protein localization in mouse spermatocytes and mutant
phenotypes taken together can provide a framework for a developmental timetable as
well shed light on roles of potential players in meiotic progress and checkpoints that may
ensure genetic fidelity.
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CHAPTER II
MATERIALS AND METHODS

Animals, Germ Cell Isolation, and Spermatocyte Enrichment
ICR (Harlan, Indianapolis, IN) and C57BL/6J mice (The Jackson Laboratory, Bar
Harbor, ME) were housed under 14 hour light/10 hour dark photoperiods at constant
temperature (21°C), with free access to standard laboratory chow and water.
Enriched fractions of germ cells were isolated from ICR male mice of varying ages.
Spermatogonial cell populations were collected from 8-day old mice, leptotene/zygotene
and early pachytene spermatocytes from 17-day old mice, and from mice at least 8 weeks
of age, pachytene spermatocytes, round spermatids, and residual bodies. Following
cervical dislocation, the testes were removed, detunicated and digested in 0.5 mg/ml
collagenase (Sigma) in Krebs-Ringer bicarbonate (KRB) buffer at 32°C for 20 minutes,
followed by digestion in 0.5 mg/ml trypsin (Sigma) in KRB at 32°C for 13 minutes. After
digestion, the germ cells were filtered through a 53 or 80 µm Nitex filter and washed
three times in KRB. Enriched fractions of spermatocytes were obtained by sedimentation
on a bovine serum albumin (BSA) gradient at unit gravity (Bellvé et al., 1993). Fractions
were assessed for morphology and purity by light microscopy using Nomarski optics.
Purified populations of germ cells were subsequently used for Western blot analysis as
described below.
Mixed germ cell populations were obtained from C57BL/6J male mice. The testes
were removed, detunicated, and enzymatically digested as described above. Germ cells
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were directly processed for fibrin-clot embedding or surface-spread preparations,
described below.

Fibrin-Clot Embedding
Spermatocytes isolated from germ cell preparations were embedded in fibrin-clots
(LeMaire-Adkins et al., 1997) by a modification previously described (Eaker et al.,
2001).

Briefly, isolated spermatocytes were brought to a concentration of 25 x 106

cell/ml. In individual wells on a Gold Seal Rite-On Fluorescent Antibody slide (Fisher
Scientific), 1.5 µl of cell suspension was added to 3 µl of fibrinogen (Calbiochem, 10
mg/ml) prepared fresh. To the cell/fibrinogen mix, 2.5 µl of thrombin (Sigma, 250 units)
was added with mixing and the clots were allowed to form. Slides were fixed in 4%
paraformaldehyde, washed in 0.2% Triton X-100 (Sigma), followed by blocking in
PBS/10% goat serum (Gibco BRL) for 30 minutes.

Surface-Spread Chromatin Preparations
Surface-spread chromatin preparations for visualization of the synaptonemal complex
were performed as previously described (Cobb et al., 1997). Briefly, germ cells were
fixed in 2% paraformaldehyde/0.03% SDS before being spread onto Shandon slides
(Shandon Lippshaw, Pittsburgh, PA). The slides were allowed to air dry and then
blocked in wash buffer (0.3% BSA, 1.0% goat serum in PBS) before being processed for
immunolocalization.
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Seminiferous Tubule Preparations with Meiotically Dividing Spermatocytes
To obtain cytological preparations enriched in meiotically dividing spermatocytes
(stage XII of the mouse seminiferous epithelium), a variation of the transillumination
procedure (Parvinen et al., 1993) was used (Eaker et al., 2001). Testes from adult
C57BL/6J mice were detunicated and digested with 0.5 mg/ml collagenase in KRB for 8
minutes at 32°C to obtain dispersed seminiferous tubules. Transillumination patterns
were observed with a dissecting microscope and used to identify stage XII tubule
segments, which were excised and transferred onto a microscope slide in KRB. The
tubules were attached to the slide by submersion in liquid nitrogen. The slides were fixed
in 3:1 ethanol/acetic acid. Prior to incubation with antibody, the slides were washed in
PBS/0.2% Triton X-100 (Sigma) followed by blocking in PBS/10% goat serum (Gibco
BRL).

Immunoblot Analysis
Preparation of cell lysates was performed as previously described (Cobb et al.,
1999b). Proteins were separated by SDS-PAGE and transferred to nitrocellulose using a
BioRad semi-dry transfer apparatus. The blots were blocked in 2% BSA, 0.1% Tween20, 100 mM NaCl, 10 mM Tris-HCl, pH 7.5, then incubated with primary antibody for
one hour. After washing in PBS/0.1% Tween-20, the blots were incubated with
horseradish peroxidase-conjugated secondary antibody (Pierce), diluted 1:2000 in
blocking solution, for one hour at room temperature. The blots were incubated with the
ECL chemiluminescent substrate (Amersham) and exposed to film according to
manufacturer’s instructions.
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Antibodies and Immunolocalization
Primary antibodies used included those that recognized the following proteins:
SYCP3 (Eaker et al., 2001), phospho-histone H2AX (UpState Biotechnology), RAD51
(Oncogene), acetylated histone H3 (UpState Biotechnology), histone H1t (see below),
phospho-histone H3 (UpState Biotechnology), pericentrin (Covance Inc.), tubulin
(Amersham), the MPM-2 epitope (UpState Biotechnology), PLK1 (UpState
Biotechnology), CENP-E (Schaar et al., 1997), CENP-F (Liao et al., 1995), Xenopus
MAD2 (Chen et al., 1996), and SUMO-1, -2, -3 (kind gifts from Dr. Michael Matunis,
The John Hopkins University, Baltimore, MD).
Following overnight incubation with primary antibody, the slides were incubated with
rhodamine- or flourescein-conjugated secondary antibodies (Pierce). Coverslips were
mounted using ProLong Antifade (Molecular Probes) containing DAPI to visualize the
DNA. Control slides were incubated with either pre-immune sera or with secondary
antibodies only in order to determine antibody specificity. Immunolocalization was
observed with an Olympus epifluorescence microscope. All images were captured to
Adobe PhotoShop using a Hamamatsu color 3CCD camera.

H1t Antibody Production
The polyclonal antibody recognizing histone H1t was prepared by Covance Research
Products (Richmond, CA) against recombinant his-tagged protein expressed in
Escherichia coli. The H1t cDNA was synthesized by RT-PCR from testicular RNA,
cloned into the pPROExHta expression vector (Gibco BRL) and sequence verified by
direct sequencing.
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Guinea pigs were injected intramuscularly with 0.5 mg of purified H1t protein in 6 M
urea followed by booster injections of 0.25 mg protein at three-week intervals. Serum
was collected at three-week intervals beginning one month after the initial injection.
The specificity of the antiserum was determined by immunoblotting using extracts
from pachytene spermatocytes know to contain the H1t protein. Extracts of germ cells
from 9-day old mice were used as a negative control. Serum collected after antigen
injection recognized protein of the appropriate molecular weight on Western blots and
stained only spermatocytes known to contain the H1t protein (mid-pachytene and later
stage spermatocytes). Pre-immune serum did not recognize proteins from spermatocytes
on Western blots.
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CHAPTER III
RESULTS AND DISCUSSION

Homologous Chromosome Synapsis and Recombination
Homologous chromosome pairing/synapsis and recombination are two events that
define meiotic prophase; successful completion of these events is critical for correct
segregation of homologous chromosomes at the first division. However, the exact timing
of these events is not understood and has been a subject of intense controversy (Santos,
1999). Therefore, we sought to order the events of meiotic prophase on cytological
preparations by documenting the appearance of recombination-related proteins to
synaptonemal complex proteins in isolated mouse spermatocytes.
One of the most useful marker proteins for documenting chromosome synapsis, and
thereby for determining cell stage, is SYCP3. SYCP3 is the major protein component
found in the axial/lateral elements of the developing synaptonemal complexes (Dobson et
al., 1994). Localization of SYCP3 is first observed in the earliest meiotic prophase
spermatocytes, at leptonema, as small patches (Figure 1). As spermatocytes progress
further into prophase the immunolocalization pattern of SYCP3 changes and is detected
along the arms of the homologous chromosomes. By pachynema, the homologous
chromosomes have completely aligned and synapsed, previously demonstrated by colocalization with SYCP1, a central element protein. Synaptonemal complex disassembly
begins in a “zipper-like” fashion, first noticeable at the ends of the chromosomes in
diplonema. By MI, the synaptonemal complex has completely disassembled, the
homologous chromosomes being held together only by their chiasmata. SYCP3 is still
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Figure 1: Immunolocalization of synaptonemal complex and recombination-related
proteins on surface-spread chromatin preparations. An antibody against the SYCP3
protein, a component of the lateral elements of the synaptonemal complex, was used to
monitor homologous chromosome pairing throughout meiotic prophase. Localization of
γ-H2AX

and RAD51 antibodies were used to document the presence of recombination-

related double-strand breaks. Spermatocytes were stained with DAPI to visualize the
chromosomes. Scale bar = 10 µm.
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detected at the kinetochores at the first division (Moens and Spyropoulos, 1995).
However, at the second division SYCP3 localization is no longer detected (Moens and
Spyropoulos, 1995).
To monitor recombination, marker proteins known to associate or signal DNA damage
were used. One of the marker proteins, phosphorylated histone H2AX, has previously
been used in similar studies to document temporal order (Mahadevaiah et al., 2001; Jang
et al., 2003). H2AX is a histone H2A variant that is phosphorylated (denoted as γH2AX) in response to DNA double-strand breaks, generated by either ionizing radiation
or recombination (Rogakou et al., 1998; Rogakou et al., 1999; Paull et al., 2000;
Mahadevaiah et al., 2001). Modification of H2AX to form γ-H2AX signals the
recruitment of repair factors to the sites of DNA damage (Paull et al., 2000; Rappold et
al., 2001). Thus by monitoring the appearance and disappearance of γ-H2AX throughout
spermatogenesis, we can infer information as to the timing and repair of DNA strand
breaks associated with recombination.
γ-H2AX

localization is detected in the earliest meiotic prophase spermatocytes, the

leptotene and zygotene spermatocytes (Figure 1). Localization appears to be scattered
throughout the nucleus, indicating the presence of unrepaired DNA strand breaks and
correlating well with past observations (Mahadevaiah et al., 2001). Upon entry into
pachynema localization of γ-H2AX decreases, implying DNA damage repair, by midpachynema localization is confined to the sex-body, comprised of the condensed X and Y
chromosomes. All γ-H2AX localization, including that found on the sex chromosomes, is
lost by metaphase I.
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Recent studies have questioned whether γ-H2AX is a truly accurate marker for
determining the presence or absence of double-strand breaks during meiosis.
Phosphorylation of H2AX has also been observed in the intermediate and type B
spermatogonia, a time when phosphorylation is not expected unless double-strand breaks
remain un-repaired or are formed anew after each division (Hamer et al., 2003).
Furthermore, the persistence of γ-H2AX at the sex body is suggestive of a specific role
for this protein in the sex vesicle, independent of recruiting repair factors to the sites of
DNA damage. Additional evidence comes from the disappearance of RAD51 foci
(discussed below) from the sex body at mid-pachynema, indicating the completion of
DNA repair, while γ-H2AX persists into diplonema.
RAD51, a RecA-like protein, is an essential component in the early stages of
recombination in yeast, associating with sites of single- or double-strand breaks (Bishop
et al., 1992; Shinohara et al., 1992; Bishop, 1994). In addition to yeast, RAD51 has also
been shown to associate with early recombination nodules formed during meiosis in both
the mouse and rat, co-localizing with the synaptonemal complex (Ashley et al., 1995;
Haaf et al., 1995; Ikeya et al., 1996; Moens et al., 1997). Localization of RAD51 is first
observed during leptonema and is seen as a punctate pattern, referred to as foci, extending
the lengths of the synaptonemal complex (Figure 1). The numbers of foci increase during
zygonema and at pachynema the most intense localization of foci is observed on the sex
chromosomes. By mid-pachynema, RAD51 localization is no longer detected, suggesting
that DNA repair is complete and thus making it a useful marker to distinguish between
early and mid-prophase spermatocytes.
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To date studies have shown that meiotic recombination is not necessary for
chromosome synapsis in either Drosophila melanogaster (McKim et al., 1998) or
Caenorhabditis elegans (Dernburg et al., 1998). However, recombination is essential for
chromosome paring in the yeast, Saccharomyces cerevisiae (Padmore et al., 1991) and
most probably in the mouse (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000;
Yuan et al., 2000; Celeste et al., 2002). The immunolocalization data previously
published by others as well as that presented here are consistent with the idea that
recombination precedes synapsis during spermatogenesis in the mouse (Mahadevaiah et
al., 2001), as double-strand breaks were detected at the very earliest stages of meiotic
prophase before significant synaptonemal complex formation.
One downside of immunolocalization studies is that the interdependence of processes,
such as recombination and homologous chromosome synapsis, can only be inferred, not
determined. Fortunately, genetic mutants have been generated helping to discern the
temporal order and interdependence of events. For example, Spo11 and Scp3 mutants
suggested recombination precedes and is necessary for promoting synapsis in mammals.
Spermatocytes deficient for Spo11, a meiosis-specific topoisomerase II protein
responsible for generating double-strand breaks, failed to undergo homologous
chromosome synapsis, indicating that SPO11-mediated recombination events precede
synapsis (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000). Male mice
deficient for SCP3, a synaptonemal complex protein, failed to form lateral/axial elements,
but still initiated recombination (Yuan et al., 2000).
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Meiotic Chromatin Modifications
As spermatocytes progress through meiosis their chromatin undergo dramatic
structural rearrangements and modifications. At the beginning of meiotic prophase the
chromosomes are in a relaxed and decondensed state, a state known to be compatible
with transcriptional activity, and a state maintained by acetylation of the core histones
(for review see Cheung et al., 2000; Jenuwein and Allis, 2001). As meiosis progresses,
the chromatin condenses and transcriptional activation begins to slow, ceasing
completely post-meiotically during spermiogenesis as the nucleus is remodeled (Monesi,
1965; Kierszenbaum and Tres, 1974; D’Agostino et al., 1978; Kierszenbaum and Tres,
1978; Hecht, 1998). However, besides regulating gene transcription, acetylation has a
unique role during spermatogenesis. Acetylation has been shown to be important for
nuclear compaction during spermiogenesis, allowing for the displacement of the core
histones by the highly basic transition proteins and the major sperm proteins, the
protamines (Oliva and Mezquita, 1982; Christensen et al., 1984; Grimes and Henderson,
1984a; Grimes and Henderson, 1984b; Meistrich et al., 1992). To document the precise
stage(s) at which acetylation occurs during spermatogenesis an antibody raised against
the acetylated form of histone H3, acetylated on lysine residues 9 and 14, was used on
fibrin-clot embedded mouse spermatocytes.
As meiosis progressed, a general overall decrease in intensity of antibody staining was
observed (Figure 2A). The most intense staining, suggesting high levels of acetylation,
was observed in the mitotic spermatogonia and leptotene spermatocytes. At zygonema,
the intensity of antibody staining decreased and remained fairly constant until a slight
increase was observed in the post-meiotic round spermatids. However, one factor
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Figure 2: Analysis of histone H3 acetylation during spermatogenesis. (A)
Immunolocalization of histone H3, acetylated on lysine residues 9 and 14, in fibrin-clot
embedded spermatocytes. Antibody intensity was highest in mitotic spermatogonia and
leptotene spermatocytes. Intensity levels decreased in mid-prophase spermatocytes. A
slight increase was observed in round spermatids. Cell stage was determined by
localization of SYCP3, a protein found in the lateral elements of the synaptonemal
complex. Scale bar = 10 µm. (B) Examination of histone H3 acetylation by Western
blotting. Histone H3 was acetylated at a constant level in all cell stages examined,
suggesting that the change in antibody intensity observed in A was due to changing cell
size and not acetylation status. G-spermatogonia, L/Z-leptotene/zygotene spermatocytes,
EP-early pachytene spermatocytes, P-pachytene spermatocytes, RS-round spermatids, Aadult whole testis.
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complicating interpretation of acetylation status from respect of antibody stain intensity is
the change in cell size that occurs during spermatogenesis. As spermatocytes progress
through prophase I, the nucleus increases in size, making it difficult to determine if a
weaker signal reflects a change in acetylation status or is due simply to an increase in cell
size. Western blot analysis of isolated spermatocytes reveals no changes in acetylated
histone H3 levels, suggesting that the observed change in intensity is attributed to a
change in cell size and not to acetylation status (Figure 2B).
The acetylation status of the chromatin, monitored by immunolocalization, does not
correlate closely with previous data on transcriptional activity during spermatogenesis.
Previous analysis indicates that transcription peaks around pachynema (Monesi, 1965;
Kierszenbaum and Tres, 1974; D’Agostino et al., 1978; Kierszenbaum and Tres, 1978;
Hecht, 1998), however, no increase in acetylation on histone H3 was detected during this
stage. A similar study reported that histones H2A, H2B, and H4 were acetylated only in
mitotic spermatogonia and preleptotene spermatocytes. Acetylation levels were
undetectable in leptotene, zygotene and pachytene spermatocytes, and through most
stages of round spermatid development (Hazzouri et al., 2000). Our results, coupled with
those of Hazzouri et al. (2000), suggest that during spermatogenesis acetylation may not
play a large role in regulating gene activity. Low levels of acetylation have also been
reported in mammalian oocytes (Kim et al., 2003) and have been linked to histone
deacetylase 1 (HDAC1) activity (Kim et al., 2003). HDAC1, along with HDAC6, are
also thought to regulate acetylation during spermatogenesis as both are found in
pachytene spermatocytes and round spermatids where acetylation levels are low
(Hazzouri et al., 2000). Much less is known about the histone acetyltransferases (HATs)
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responsible for acetylation, although previously uncharacterized HATs, CDYL and CDY,
have been identified in the human and mouse, respectively (Lahn et al., 2002). CDYL
and CDY are both expressed in maturing spermatids and are thought to regulate the
histone-to-protamine transition.
Besides the core histones, the linker H1 histones play a very important role in
regulating chromatin structure and transcription (for review see Hartzog and Winston,
1997; Wolffe, 1997; Wolffe et al., 1997). Histone H1t is a testis-specific linker histone
transcribed exclusively in mid- to late-meiotic prophase spermatocytes (Grimes et al.,
1992; Drabent et al., 1993; Drabent et al., 1995). Histone H1t expression begins at midpachynema, replacing the somatic linker histones H1.1 and H1.2 (Meistrich et al., 1985).
H1t expression persists into the early stages of elongating spermatids where it constitutes
over half of the total H1 histone complement (Meistrich et al., 1985; Grimes, 1986;
Drabent et al., 1998). Analysis of H1t to condense chromatin showed that it has the
lowest capacity of all the linker H1 subtypes to regulate condensation, perhaps preserving
an open chromatin conformation to facilitate meiosis-specific events (DeLucia et al.,
1994; Khadake and Rao, 1995). However, H1t is not necessary for successful completion
of spermatogenesis as H1t-deficient spermatocytes progress normally, even with
enhanced levels of H1.1 and H1.2 expression (Drabent et al., 2000; Lin et al., 2000).
Histone H1t is first detected in mid-pachynema when the homologous chromosomes
are fully synapsed (Figure 3). Interestingly, the appearance of histone H1t also coincides
with acquisition of competence to condense MI chromosomes in response to OA
treatment (Cobb et al., 1999a). Histone H1t localization persists through the first and
second meiotic divisions and is observed in both round and elongating spermatids. Since
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Figure 3: Analysis of chromosomal modifications in surface-spread mouse
spermatocytes. Beginning in meiotic prophase the somatic linker histones, H1.1 and
H1.2, are replaced by the testis-specific histone, histone H1t. Deposition of histone H1t
is first observed in mid-pachytene spermatocytes with localization extending throughout
the entire chromatin area. Localization persists through the division phase and is
observed in round and elongating spermatids. An antibody against the phosphorylated
form of histone H3 was used to monitor chromosome condensation. Localization first
appeared in the heterochromatic regions at diplonema and extended throughout the entire
chromatin area at MI. Cell stage was determined by localization of SYCP3 and/or DAPI.
Scale bar = 10 µm.
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histone H1t is not expressed in early pachytene spermatocytes, it is one of the most useful
marker proteins for discriminating early from mid- to late-pachytene spermatocytes.
Another histone modification that occurs just prior to the division phase is the
phosphorylation of histone H3. Phosphorylation of histone H3, on serine 10, has been
linked to both mitotic and meiotic chromosome condensation (Van Hooser et al., 1998;
Wei et al., 1998; Cobb et al., 1999b; Wei et al., 1999). During spermatogenesis,
phosphorylation is detected late in meiotic prophase at diplonema in the heterochromatic
regions (Figure 3) (Cobb et al., 1999b). As the spermatocyte progresses into MI, the
phosphorylation of histone H3 radiates from the heterochromatic regions to cover the
entire chromatin area. After the second meiotic division, phosphorylation of histone H3
is no longer detected. A similar pattern has also been reported for mitotically diving cells
(Hendzel et al., 1997). Until recently the kinase(s) identified in regulating histone H3
phosphorylation were not known. These kinases have since been classified as the Aurora
kinases and have been shown to regulate H3 phosphorylation in Drosophila, C. elegans,
Xenopus, and mammalian cells (Hsu et al., 2000; Giet and Glover, 2001; Murnion et al.,
2001; Scrittori et al., 2001; Crosio et al., 2002).
Another chromatin modification recently found to occur during spermatogenesis is
sumoylation. SUMO (small ubiquitin-related modifier) is conjugated to proteins in a
similar process to ubiquitination (for review see Wilson and Rangasamy, 2001;
Sternsdorf et al., 2003). However, unlike ubiquitination, sumoylation does not target
proteins for degradation. It has been proposed that SUMO may act like phosphorylation,
changing the conformation of proteins and thereby altering function. Some have argued
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that it serves as a transferable protein-protein interface while others believe that it
competes with ubiquitin for balancing protein degradation and stability.
SUMO has previously been shown to be an important modification during mitosis in
the budding yeast and meiosis in the fly. Overexpression of SUMO-1, known also as
SMT3, has been shown to regulate centromeric cohesion by modifying DNA
topoisomerase II in S. cerevisiae (Bachant et al., 2002). A role for the UBC9 (ubiquitinconjugating 9) homolog in Drosophila, lesswright (lwr), which covalently attaches
SUMO to proteins, was found to mediate homologous chromosome disjunction during
the first meiotic division (Apionishev et al., 2001). However, as mentioned above, it is
not known how sumoylation regulates these processes.
Three SUMO genes have been identified in mice and humans, while only copy has
been found in S. cerevisiae, C. elegans, and Drosophila. Localization of SUMO-1, -2,
and -3 proteins on spreads of isolated mouse spermatocytes produced identical
localization patterns, even though each has demonstrated a preference for different
proteins (Figure 4). SUMO is not detected in the earliest stages of meiotic prophase.
Localization appears in early pachynema and is concentrated on the sex body.
Localization at the sex body persists until diplonema, but SUMO is not detected at MI.
In a few diplotene-staged spermatocytes, SUMO localized to the heterochromatic
regions.
The localization of SUMO to the sex chromosomes midway through meiotic prophase
is intriguing and closely resembles the localization pattern observed with γ-H2AX.
Localization of both SUMO and γ-H2AX to the sex chromosomes demonstrates active
sumoylation and phosphorylation in pachytene and diplotene spermatocytes, perhaps
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Figure 4: Localization of SUMO-1, -2, and -3 on surface-spread chromatin preparations.
No positive immunoreactivity was observed in leptotene (not shown) and zygotene
spermatocytes incubated with a SUMO-1 antibody. Localization was first observed in
pachytene spermatocytes and was concentrated over the sex body. This localization
pattern persisted into diplonema. No positive immunoreactivity was observed in
metaphase I spermatocytes. Identical immunolocalization patterns were observed with
the antibodies against SUMO-2 and SUMO-3. Cell stage was determined by localization
of SYCP3, a protein found in the lateral elements of the synaptonemal complex. Scale
bar = 10 µm.
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revealing a novel regulatory mechanism governing transcription or pairing of the X and
Y chromosomes. Additionally, the localization of SUMO suggests that it does not
regulate topoisomerase II throughout spermatogenesis. Topoisomerase II has previously
been shown to localize to centromeric heterochromatin throughout spermatogenesis, from
leptonema to MI (Cobb et al., 1999b), while SUMO was detected at the heterochromatin
in only a few select spermatocytes at diplonema. Thus if SUMO plays a role in
centromeric cohesion it must be just prior to the first division.

Preparing for Division - Spindle Assembly and Formation
Monitoring the proteins involved in spindle assembly and formation during
spermatogenesis has previously been difficult because most preparations are based on
variations of the surface-spread technique, a harsh method that does not conserve nuclear
architecture or retain soluble proteins. Recently, we adapted a fibrin-clot procedure
previously used for oocytes to study the appearance and localization of proteins involved
in meiotic spindle assembly. This preparation preserves both the three-dimensional
structure of the spermatocyte and the soluble proteins, allowing visualization of structural
elements such as the meiotic spindle.
Localization of pericentrin can be used to follow meiotic spindle assembly.
Pericentrin, a protein found in the centriolar region of the microtubule organizing centers
(MTOCs), is necessary for bipolar spindle development. Pericentrin was detected early
in meiotic prophase, in the leptotene spermatocytes, as a punctate spot (Figure 5). At
diplonema the localization pattern of pericentrin changed, instead of a single punctate
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Figure 5: Localization of proteins involved in spindle assembly/formation. Isolated
spermatocytes were embedded in fibrin-clots and incubated with antibodies against the
centrosomal protein, pericentrin, or tubulin, a microtubule associated protein, to monitor
spindle assembly. Both antibodies localized to all stages of meiotic prophase
spermatocytes with localization primarily confined to the centrosome. At metaphase I, a
dramatic re-localization of both proteins was observed. Pericentrin localization appeared
at opposite poles of the spermatocyte, indicating centrosomal division, and tubulin was
visible on spindle microtubules. An antibody against the synaptonemal complex protein,
SCYP3, was used to determine cell stage. Scale bar = 10 µm.
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spot, two distinct spots were observed indicating centrosomal division. By MI, the two
punctate spots had migrated to opposite poles of the cell.
Tubulin, like pericentrin, localized throughout meiotic prophase, enveloping the edge
of the nucleus (Figure 5). Localization appeared more prominent near the developing
MTOCs. At MI a dramatic re-localization was observed that reflected assembly of
microtubules forming the metaphase I spindle.
Interestingly, the localization of pericentrin and tubulin in leptotene spermatocytes
demonstrate that some of the components needed for spindle development are present
throughout the long meiotic prophase. However, it is not known what signals the
dramatic re-localization of proteins at MI.

Protein Phosphorylation Increases at the G2/MI Transition
One factor that may govern the dramatic re-localization of proteins observed at MI is
protein phosphorylation. The MPM-2 antibody, which recognizes phospho-epitopes on
proteins phosphorylated during mitosis and meiosis, reveals a dramatic increase in
phosphorylation as spermatocytes progress through the division phase (Figure 6). Some
staining with MPM-2 was detected in leptotene through diplotene spermatocytes.
Interestingly, much of the staining was confined to the condensed sex chromosomes. At
MI, MPM-2 staining increased in intensity and encompassed the entire nuclear area, a
pattern persisting into anaphase I.
The increase in MPM-2 staining intensity suggests the importance of phosphorylation
reactions in regulating the meiotic divisions. A kinase that may be necessary for this
transition is the Polo-like kinase 1 (PLK1). Named after the polo gene of D.
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Figure 6: MPM-2 localization throughout meiotic prophase and the division phase.
Isolated mouse spermatocytes were embedded in fibrin-clots, to monitor phosphorylation
the MPM-2 antibody, which recognizes phospho-epitopes found on proteins during
mitosis and meiosis, was used. A dramatic increase in phosphorylation was observed as
spermatocytes exited prophase and entered the division phase. Phosphorylation persisted
into anaphase I. Cell stage was determined by immunolocalization of SYCP3 or DAPI.
Scale bar = 10 µm.
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melanogaster, Polo-like kinases are a distinct class of serine/threonine protein kinases
and have emerged as major regulators of mitotic divisions (for review see Glover et al.,
1998; Nigg, 1998). The Polo-like kinases have been linked to several mitotic events
including centrosome maturation and duplication, spindle development (for review see
Glover et al., 1998; Nigg, 1998) and sister chromatid segregation (Alexandru et al., 2001;
Sumara et al., 2002). A possible role for PLK1 in DNA damage repair has also been
proposed (Smits et al., 2000; Tsvetkov et al., 2003).
Much less is known of the role(s) of PLK1 in meiosis. PLK1 has been observed at the
spindle poles and centromeres during the meiotic divisions in mammalian oocytes
(Wianny et al., 1998; Pahlavan et al., 2000; Tong et al., 2002). Besides
immunolocalization studies, functional studies have defined a more precise role for PLK1
during mammalian meiosis. Microinjection of PLK1 antibodies into oocytes decreased
the rate of germinal vesicle breakdown, and prevented organized spindle formation (Tong
et al., 2002; Fan et al., 2003). However, in MI spermatocytes, PLK1 was not localized to
the meiotic spindle (Figure 7A). Instead localization was detected before metaphase at
the centromeres. Western blotting revealed that PLK1 was expressed at fairly consistent
levels in the mitotic spermatogonia to the haploid round spermatids (Figure 7B).
Although localization of PLK1 was not observed at the meiotic spindle, localization to
the centromeres is consistent with a role for PLK1 in the spermatocyte’s G2/MI
transition. Given this localization, PLK1 might play a role in the spindle checkpoint
(discussed below), monitoring the correct attachment of homologous chromosomes to the
spindle microtubules.
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Figure 7: Analysis of PLK1 expression and localization during the meiotic G2/MI
transition. (A) Immunolocalization of PLK1 in late prophase and metaphase I
spermatocytes. PLK1 localized to the centromeres of meiotic chromosomes during
prophase I. No change in localization was detected as spermatocytes entered the first
division phase. Cell stage was determined by localization of SYCP3 or DAPI staining.
Scale bar = 10 µm. (B) Expression analysis of PLK1. PLK1 is expressed throughout
spermatogenesis, protein was detected in the mitotic spermatogonia, meiotic prophase
spermatocytes and the post-meiotic germ cells. No increase in expression was observed
upon OA treatment, which results in a precocious metaphase I-like state. Gspermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early pachytene
spermatocytes, P-pachytene spermatocytes, OA-OA treated pachytene spermatocytes,
RS-round spermatids, RB-residual bodies, A-adult whole testis.
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Localization of Spindle Checkpoint Proteins
Eukaryotic systems have developed a checkpoint to monitor the proper attachment of
chromosomes to the mitotic spindle (Rieder et al., 1995). The kinetochores, located at
the centromeric heterochromatin, are essential in regulating this checkpoint. Numerous
proteins comprise the kinetochores in both yeast and mammals (Pluta et al., 1995),
centromere-protein E (CENP-E), is one of the proteins found at the kinetochore (Yen et
al., 1992). CENP-E is a kinesin-like motor protein whose expression peaks at metaphase
in mitotic cells (Yen et al., 1992). Shortly after nuclear envelope disassembly, CENP-E
binds to the kinetochores where it remains as the chromosomes align on the metaphase
plate (Yen et al., 1991). CENP-E has since been localized to the kinetochores of meiotic
chromosomes in mouse spermatocytes (Kallio et al., 1998) and pig oocytes (Lee et al.,
2000).
CENP-E is expressed throughout all stages of spermatogenesis, including the mitotic
spermatogonia (Figure 8A). Expression decreased slightly in leptotene and zygotene
spermatocytes, but gradually increased in pachynema and diplonema. Expression was
not found to increase after treatment of spermatocytes with OA, a phosphatase inhibitor
that induces a precocious metaphase I-like state. Immunolocalization studies, consistent
with expression analysis, showed a dramatic change in localization from the developing
centrosomal region in prophase to the kinetochores in prometaphase and metaphase
spermatocytes (Figure 8B). Centromere protein F (CENP-F), a related kinesin-like motor
protein, produced an identical expression and localization pattern to CENP-E (Figures 8A
and B).
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Figure 8: Expression analysis and localization of checkpoint proteins, CENP-E and
CENP-F, throughout spermatogenesis. (A) Expression analysis of the checkpoint
proteins. CENP-E and CENP-F were both expressed in mitotic spermatogonia.
Expression declined upon entry into meiotic prophase, but increased around pachynema.
Expression was detected in the post-meiotic round spermatids, but not in residual bodies.
No increase in expression was observed upon treatment with the phosphatase inhibitor,
OA, shown to induce a precocious metaphase I-like state. G-spermatogonia, L/Zleptotene/zygotene spermatocytes, EP-early pachytene spermatocytes, P-pachytene
spermatocytes, OA-OA treated pachytene spermatocytes, XII-stage XII micro-dissected
tubules, RS-round spermatids, RB-residual bodies, A-adult whole testis. (B) CENP-E
localized to the centrosomal regions of meiotic prophase spermatocytes beginning at
zygonema. As spermatocytes began the transition from prophase into metaphase a shift
in the localization pattern occurred. At prometaphase, CENP-E localization was no
longer centrosomal, but was detected at the kinetochores, becoming more evident at
metaphase I. An identical localization pattern was observed for CENP-F; however,
centrosomal localization was not as pronounced in prophase spermatocytes. Cell stage
was determined by either SYCP3 or tubulin localization. Scale bar = 10 µm.
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Mitotic-Arrest Deficient 2 (MAD2) is another protein involved in the mitotic spindle
checkpoint. MAD2, first identified in the budding yeast, is involved in the “anaphase
wait” signal, which arrests the cells in metaphase until all of the chromosomes have
aligned on the metaphase plate. MAD2 is recruited to unattached kinetochores resulting
in its activation, through an unknown mechanism, and prevents the onset of anaphase by
inhibiting the anaphase promoting complex (APC), responsible for the ubiquitination of
proteins leading to their destruction (for review see Shah and Cleveland, 2000).
An antibody against the Xenopus MAD2 protein (XMAD2) was used to determine
both the expression and immunolocalization of this checkpoint protein in meiotic
spermatocytes. Western analysis revealed ubiquitous expression of XMAD2 from the
mitotic spermatogonia to the round spermatid stage (Figure 9A). Immunolocalization of
XMAD2 revealed staining at the centrosomal region and the kinetochores (Figure 9B).
This pattern was observed throughout meiotic prophase and persisted into the division
phase. Previously, a similar localization pattern was reported by Kallio et al. (2000) for
mouse spermatocytes.
Immunolocalization places CENP-E, CENP-F, and XMAD2 at the right place and
time for acting in a spindle assembly checkpoint during meiosis. Furthermore, a recent
study analyzing chromosome alignment in mice containing Robertsonian translocations
provides additional evidence for a meiotic spindle checkpoint (Eaker et al., 2001).
Robertsonian heterozygous mice have an increased frequency of spermatocytes with
misaligned condensed chromosomes at the first division. Spermatocytes with misaligned
chromosomes are eliminated by apoptosis, presumably to prevent the production of
aneuploid gametes. This implies that a checkpoint process must be in place and capable
67

Figure 9: Examination of XMAD2 expression and localization during spermatogenesis.
(A) Expression analysis of XMAD2 determined by Western blotting. A consistent level
of XMAD2 expression was observed in all stages of spermatogenesis, from the mitotic
spermatogonia to the haploid round spermatids. Treatment with OA did not increase
expression levels. G-spermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early
pachytene spermatocytes, P-pachytene spermatocytes, OA-OA treated pachytene
spermatocytes, RS-round spermatids, A-adult whole testis. (B) Localization of XMAD2
in fibrin-clot embedded spermatocytes and stage XII micro-dissected tubules. XMAD2
was detected at the kinetochores of the meiotic chromosomes beginning at leptonema.
Localization became more pronounced in zygonema and appeared in the centrosomal
region. No change in the localization pattern occurred upon entry into the division phase.
Cell stage was determined by localization of SYCP3. Scale bar = 10 µm.
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of identifying aberrant meioses. Furthermore, the intensity of CENP-E and CENP-F
staining was increased on kinetochores that were not properly attached to the meiotic
spindle, similar to situations reported in mitotic systems. Not only do these results
suggest that a meiotic spindle checkpoint is in place, but also they identify new players
involved in the meiotic G2/MI transition, leading to a better overall understanding of
meiotic events.

Conclusion
This work has contributed to building a meiotic “timeline” documenting the major
events of meiotic prophase and the division phase. The immunolocalization data
presented here, as well as that previously published by others, enables us to determine
what events occur, in what order they occur, and how they may be interrelated by
temporal sequence. By comparing the appearance of recombination-related proteins (γH2AX and RAD51) to a synaptonemal complex protein (SYCP3) we were able to infer
that recombination precedes synapsis in mouse spermatocytes. Additionally, by
monitoring chromatin modifications, the appearance of histone H1t and phosphorylation
of histone H3, we were able to determine the time of histone replacement, signaling
nuclear remodeling, and chromosome condensation, which coincided with spindle
development. Perhaps more importantly we were able to identify potential players
(PLK1, CENP-E, CENP-F, and XMAD2) in the G2/MI transition and by their
localization were able to suggest participation in a meiotic spindle checkpoint.
Identification of new players involved in the G2/MI transition is critical to advancing our
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understanding of meiosis, since so little is known of the players regulating this transition
in spermatocytes.
The establishment of the temporal order of events not only allows us to infer
regulatory relationships and develop testable hypothesis, but also creates a valuable
reference to which we can compare mutant mouse models. Analysis of two mutant
mouse models using this approach will be discussed in Part IV.
Perhaps the major drawback from immunological studies is the inability to precisely
determine gene function. Although our data suggests recombination precedes
homologous chromosome synapsis, we were unable to demonstrate an interdependence
of the two processes. However, the recent advances of knockout technology and ongoing
mutagenesis projects have and are continuing to provide mutant mouse models to
answers the questions raised by immunocytology. The localization patterns compiled
here are only a starting point for the meiotic timeline, for as new genes/proteins are
discovered, their expression patterns will be added and will to continue to increase our
knowledge of this critical cell division process.
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PART III

ELUCIDATION OF THE PLAYERS INVOLVED IN THE MEIOTIC G2/MI
TRANSITION IN MALE MICE
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ABSTRACT

Spermatogenesis is comprised of a series of cell divisions, both mitotic and meiotic.
Remarkably little is known of the regulatory cascade of kinases that are required for the
meiotic divisions in spermatocytes. We have investigated the meiotic role of the
extracellular signal-regulated protein kinases (ERKs), more commonly known as the
mitogen-activated protein kinases (MAPKs), taking advantage of both inhibitors and
mouse genetic models. ERK1 and ERK2 are expressed throughout spermatogenesis, but
are phosphorylated predominantly in the mitotically dividing spermatogonia. Treatment
of pachytene spermatocytes with okadaic acid (OA), previously shown to induce a
premature transition to metaphase I (the G2/MI transition), resulted in an increase in the
phosphorylation levels and activation state of ERK1/2, revealing a possible role for these
kinases in the OA-induced meiotic G2/MI transition. However, treatment of
spermatocytes with a specific inhibitor, U0126, of the ERK-activating kinase, MEK1/2,
did not inhibit OA-induced MAPK activation or chromosome condensation, suggesting
that the MAPKs may be activated by a MEK-independent mechanism in pachytene
spermatocytes. Analysis of spermatocytes deficient for Mos, the mitogen-activated
protein kinase kinase kinase responsible for MAPK activation in oocytes, suggest that
MOS is not needed in vivo or in vitro during spermatogenesis, as mutant spermatocytes
activate the MAPKs and condense bivalent chromosomes at levels equivalent to their
heterozygous littermate controls. Surprisingly, treatment of pachytene spermatocytes
with butyrolactone I, an inhibitor of the catalytic subunit of maturation promoting factor
(MPF), not only prevented OA-induced chromosome condensation, but also inhibited
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MAPK activation. These results suggest that MPF may directly or indirectly regulate
MAPK activity during spermatogenesis, revealing a novel regulatory pathway.
Additionally, the role(s) of the CDC25C protein phosphatase in the transition from
meiotic prophase to the division phase was investigated using spermatocytes isolated
from Cdc25C-deficient mice. Cdc25C-/- spermatocytes condensed bivalent chromosomes
and activated MPF in response to OA treatment at the same levels as their heterozygous
controls; therefore spermatocytes must possess a CDC25C-independent pathway for MPF
activation. Taken together, these studies reveal that spermatocytes do not depend on
MOS or CDC25C for progression into the division phase. Additionally, these studies
provide insight into the regulation of MAPK activation during spermatogenesis, revealing
differences in regulation between male and female meiosis.
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CHAPTER I
INTRODUCTION

Meiosis is the cell division process that is responsible for the production of haploid
gametes and thus is required by all sexually reproducing organisms. In males, meiosis
occurs during spermatogenesis. Spermatogenesis is initiated at puberty by production of
spermatogonia from the spermatogonial stem cells, controlled by both endocrine
regulation and cell-cell interactions (Parvinen et al., 1986; Toppari et al., 1991;
Kierszenbaum, 1994). After a set number of mitotic divisions by the differentiated
spermatogonia, meiosis is initiated. It is during the extended meiotic prophase that many
dynamic rearrangements, including homologous chromosome pairing, recombination,
and chromatin remodeling occur, followed by synaptonemal complex breakdown,
chromosome condensation and spindle assembly during the division phase. The
transition from meiotic prophase (G2) to metaphase of the first meiotic division (MI) is
here referred to as the G2/MI transition. Unfortunately, the regulatory mechanisms
governing the complex processes at the meiotic G2/MI transition have not been fully
elucidated, leading to gaps in our understanding of the processes.
Previous studies have demonstrated that reversible protein phosphorylation is involved
in the regulation of both mitotic and meiotic cell divisions, encompassing processes such
as centrosome separation, chromosome segregation and cytokinesis (for review see
Pelech et al., 1990). More specifically, protein phosphorylation accompanies
synaptonemal complex disassembly, chromosome condensation and nuclear envelope
breakdown in meiosis, in addition to regulating aspects of both metaphase and telophase
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(Wiltshire et al., 1995; Cobb et al., 1999b; Tarsounas et al., 1999). Specifically, studies
from our laboratory have shown a dramatic increase in levels of phosphorylated proteins
as spermatocytes exit prophase and enter metaphase, implying that reversible protein
phosphorylation plays an important role in the regulation of the meiotic division during
spermatogenesis (as discussed in Part II). Although phosphorylation reactions are
presumed essential, the roster of specific kinases required for the successful completion
of the G2/MI transition during male meiosis is not yet known.
Experimental analysis of the G2/MI transition in males has been difficult, due
primarily to the low number of spermatocytes naturally progressing through this
transition at any one time. This in part was overcome by the discovery that okadaic acid
(OA) treatment of pachytene spermatocytes overrides the normal checkpoints that delay
entry into metaphase I, inducing a precocious metaphase I-like state, characterized by
condensation of bivalent metaphase chromosomes and synaptonemal complex breakdown
(Wiltshire et al., 1995). One way by which OA treatment is thought to act is by
stimulating the activation of maturation promoting factor (MPF), a kinase identified as
essential in both mitotic and meiotic divisions (Chapman and Wolgemuth, 1994;
Wiltshire et al., 1995; Cobb et al., 1999b).
MPF is a complex of two subunits, the catalytic p34cdc2 (CDC2) subunit and the
CYCLIN B1 regulatory subunit. Activation of MPF occurs through a two-step process
involving the phosphorylation of Thr161 by the cdk-activating kinase and the
dephosphorylation of Thr14 and Tyr15 by the CDC25C phosphatase (Nurse 1990; Pines
and Hunter, 1990; Norbury et al., 1991). However, the role of CDC25C in MPF
activation has recently come into question. Mice lacking Cdc25C have no phenotype and
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are fertile (Chen et al., 2001). Since MPF is active in mitotic cells (Chen et al., 2001),
the normal phenotype suggests that either CDC25C is not required or that there are
redundant phosphatases that substitute. The requirement for CDC25C in male meiotic
divisions is investigated here.
MPF is required for the meiotic G2/MI transition of spermatocytes in vitro. Pachytene
spermatocytes pre-treated with butyrolactone I, a potent and specific inhibitor of the
cyclin-dependent kinases (Kitagawa et al., 1993), failed to condense bivalent
chromosomes in response to OA treatment (Cobb et al., 1999b). Although some
chromosome condensation occurred the individualization of bivalent chromosomes was
dramatically inhibited (Cobb et al., 1999b). Phosphorylation of histone H3, known to be
a hallmark of chromosome condensation, was unaffected after butyrolactone I treatment,
suggesting both that phosphorylation of histone H3 is not sufficient for condensation of
chromosomes and that MPF is not involved in the regulation of histone H3
phosphorylation (Cobb et al., 1999b). If MPF is not required for histone H3
phosphorylation, at least one other kinase must play a key role in the spermatocyte’s
G2/MI transition.
The extracellular signal-regulated protein kinases (ERKs), more commonly known as
the mitogen-activated protein kinases (MAPKs), have been implicated in regulating
chromosome condensation at the G2/MI transition during oogenesis (Verlhac et al., 1994;
Kubelka et al., 2000; Sun et al., 2002), and also during spermatogenesis (Sette et al.,
1999; Di Agostino et al., 2002). ERK1 and ERK2, the two main isoforms of the MAP
kinases, are serine/threonine kinases that are activated in response to dual
phosphorylation on threonine and tyrosine residues by the MAPK kinases, MEK1/2.
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Activation of MEK1/2 has been shown to occur by two separate pathways (Figure 1). In
mitotically dividing cells, MEK1/2 are activated by an extracellular signaling pathway
containing RAS and the MAPK kinase kinase, RAF. However, at least in females, the cmos protooncogene has been show to be required for MAPK activation during meiosis
(Araki et al., 1996; Choi et al., 1996; Verlhac et al., 1996).
To date most of the information known about the roles and regulation of the MAPKs
during meiosis was acquired by studying oocytes. Experiments using both mouse and
Xenopus laevis oocytes have demonstrated the necessity of MEK1/2 and MOS in
activation of the MAPKs. Injection of either antisense c-mos oligonucleotides or
antibodies against MEK1/2 not only prevented meiotic progression and failure of MII
arrest, but also prevented the activation of ERK1/2 (Sagata et al., 1988; O’Keefe et al.,
1989; Sagata et al., 1989; O’Keefe et al., 1991; Kanki and Donoghue, 1991; Gebauer et
al., 1994; Kosako et al., 1994). Generation of mice deficient for Mos supported previous
in vitro observations as to the necessity of MOS in regulating oogenesis. However, male
mice lacking the MOS protein progressed normally through spermatogenesis without any
obvious impairment in fertility, revealing differences in cell cycle regulation in male and
female meiosis (Colledge et al., 1994; Hashimoto et al., 1994; Gross and Cooper, 2002).
Recently, Sette et al. (1999) and Di Agostino et al. (2002) explored the role of the
MAPKs in the G2/MI transition during spermatogenesis, in particular focusing on the
regulation of chromosome condensation. To assess whether ERK1 and/or ERK2 were
important in chromosome condensation, pachytene spermatocytes were cultured in the
presence of PD98059 or U0126, both inhibitors of the ERK activating kinases, MEK1/2
(Favata et al., 1998). After treatment with PD98059 or U0126, MAPK activity in
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Figure 1: Schematic model of the activation of the MAPKs, ERK1/2. The MAPKs are
activated in response to a wide variety of extracellular signals. The signal is transduced
from the receptor at the cell surface to the small GTP binding protein RAS, which
activates the MAPK kinase kinase, RAF. RAF in turn phosphorylates the ERKactivating kinases, MEK1/2, which are then able to phosphorylate and activate the
MAPKs. The MAPK kinase kinase, MOS, expressed primarily in germ cells, has also
been shown to stimulate MAPK activity through regulation of MEK1/2 phosphorylation
during oogenesis.
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pachytene spermatocytes was inhibited and OA-induced chromosome condensation did
not occur, suggesting that the MAPKs are involved in regulating the spermatocyte’s
G2/MI transition (Sette et al., 1999; Di Agostino et al., 2002). Evidence suggests that the
MAPKs could regulate chromosome condensation through p90rsk2 and the NIMA-related
kinase 2 (Nek2) (Di Agostino et al., 2002), which previously had been shown to localize
to condensed MI chromosomes (Tanaka et al., 1997; Rhee and Wolgemuth, 1997).
Although chromosome condensation was inhibited after treatment with U0126,
phosphorylation of histone H3 was unaffected (Di Agostino et al., 2002), supporting
previous results that the phosphorylation of histone H3 is not sufficient for meiotic
chromosome condensation and that at least two independent pathways for chromosome
condensation exist in the spermatocyte, one governing H3 phosphorylation and another
dependent on MPF and/or MAPK activity (Cobb et al., 1999b).
This study was designed to investigate the kinases involved in regulating the meiotic
G2/MI transition in mouse spermatocytes, specifically the role of the MAPKs during this
transition. The expression and role in spermatocytes of upstream kinases (MOS,
MEK1/2), shown to be necessary for ERK1/2 activation in oocytes, has been
investigated. The results provide further insight to the mechanism(s) by which OA
stimulates a precocious G2/MI transition, since Cdc25C-deficient pachytene
spermatocytes still condense bivalent chromosomes and activate MPF. The data reveal
complex and possibly overlapping signal transduction pathways regulating the naturally
occurring G2/MI transition and the OA-induced transition in spermatocytes. Ultimately,
this information will contribute to better understanding of meiosis in the male and
sexually dimorphic differences in its regulation.
90

CHAPTER II
MATERIALS AND METHODS

Animals and Germ Cell Isolation
ICR mice were obtained from Harlan (Indianapolis, IN), while those carrying the Mos
and Cdc25C targeted mutations were generously provided by Drs. John Eppig (The
Jackson Laboratory, Bar Harbor, ME) and Helen Piwnica-Worms (Washington
University, St. Louis, MO), respectively. Offspring of mice carrying the targeted
mutations were genotyped by PCR reactions using DNA obtained from tail tips and
primers specific for both the normal and targeted alleles (Colledge et al., 1994; Hirao and
Eppig; 1997; Chen et al., 2001). All mice were housed under 14 hour light/10 hour dark
photoperiods at constant temperature (21°C), with free access to standard laboratory chow
and water.
Enriched fractions of germ cells were isolated from male mice of varying ages.
Spermatogonial cell populations were collected from 8-day old mice, leptotene/zygotene
and early pachytene spermatocytes were collected from 17 day-old mice, while pachytene
spermatocytes, round spermatids, and residual bodies were collected from mice at least 8
weeks of age. Following cervical dislocation the testes were removed, detunicated, and
digested in 0.5 mg/ml collagenase (Sigma) in Krebs-Ringer bicarbonate (KRB) buffer at
32°C for 20 minutes, followed by a subsequent digestion in 0.5 mg/ml trypsin (Sigma) at
32°C for 13 minutes. After digestion, the germ cells were filtered through a 53 or 80 µm
Nitex filter and washed three times in KRB containing 0.5% bovine serum albumin
(BSA) (Sigma). The single-cell suspension was sedimented at unit gravity through a 291

4% BSA gradient, as described previously by Bellvé et al. (1993). The gradient was
collected after two and a half hours at a rate of 10 mls/45 seconds. Fractions were
assessed for morphology and purity by light microscopy using Nomarski optics.
Mixed germ cell populations were obtained from 7, 12, 17, and 22-day old mice, as
well as from adult mice at least 8 weeks of age. The testes were removed, detunicated,
and enzymatically digested as described above.

Cell Culture and Treatment
Enriched fractions of purified spermatocytes or isolated populations of mixed germ
cells were washed and resuspended in HEPES-buffered MEMα culture medium (Sigma)
supplemented with 25 mM NaHCO3, 5% v/v fetal bovine serum (FBS) (Gibco BRL), 20
mM sodium lactate, 59 µg/ml penicillin, 100 µg/ml streptomycin, as previously described
(Handel et al., 1995) or in MEM (Sigma) culture medium supplemented with 0.5% BSA,
1 mM sodium pyruvate, 2 mM sodium lactate, 59 µg/ml penicillin and 100 µg/ml
streptomycin (Sette et al., 1999; Di Agostino et al., 2002) . The cells were plated at a
concentration of 1x106 cells/ml or 2.5x106 cells/ml in 4-well Nunclon dishes (Fisher
Scientific). The cells were cultured at 32°C in a humified atmosphere with 5% CO2.
To investigate MAPK activation, spermatocytes were cultured in the presence of the
MEK inhibitor U0126 (Calbiochem) for 2 to 12 hours. U0126 was dissolved at 5 mM in
dimethyl sulfoxide (DMSO) and added to cultures at 10 or 40 µM. Spermatocytes were
cultured in the presence of the inactive analog of U0126, U0124 (Calbiochem), for 12
hours. U0124 was dissolved at 10 mM in DMSO and was added to cultures at 100 µM.
Control cultures were given equivalent volumes of solvent alone. After 12 hours of
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culture, spermatocytes were treated with either 0.5 or 5 µM OA (Calbiochem), dissolved
at 244 µM in 100% ethanol, for 5 hours.
Treatment with butyrolactone I was performed as described by Cobb et al. (1999b). In
brief, spermatocytes were treated for 30 minutes with butyrolactone I (Biomol) prior to
the addition of 0.5 or 5 µM OA. Butyrolactone I was dissolved at 25 mM in DMSO and
added to cultures in a range from 10-100 µM. After treatment cells were harvested and
processed for immunoblot analysis, H1 kinase assays, in-gel kinase assays or for
cytological analysis as described below.

Preparation of Cell Lysates
Isolated or purified germ cell fractions were lysed as described by Cobb et al. (1999a).
In brief, isolated or cultured spermatocytes were collected by centrifugation, washed
twice in KRB, and frozen at -80°C. Upon thawing, the cells were lysed in lysis buffer
containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% NP-40, 50 mM NaF, 1 mM
Na3VO4, 1 mM DTT, 1 mM PMSF, 10 µg/ml soybean trypsin inhibitor, 10 µg/ml
leupeptin, 10 µg/ml aprotinin, and 5 µg/ml DNase for 30 minutes on ice. Following lysis,
the cells were homogenized with a microcentrifuge pestle and centrifuged at 14,000 rpm
at 4°C for 10 minutes. The supernatant was saved and used in subsequent immunoblot
and kinase assays. Total protein concentration was determined by the Bradford method
(BioRad).
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Immunoblot Analysis
Twenty micrograms of total protein from each sample were separated on 10 % SDSPAGE gels and transferred to nitrocellulose using a BioRad semi-dry transfer apparatus.
The blots were blocked in either 5% nonfat milk or 2% BSA dissolved in Tris-buffered
saline/0.1% Tween (TBST) for one hour at room temperature. The blots were probed
with anti-ERK1 (Santa Cruz Biotechnology), anti-ERK2 (Santa Cruz Biotechnology),
anti-P-MAPK (Promega), anti-MEK1 (UpState Biotechnology), anti-MEK2 (Cell
Signaling) or anti-P-MEK1/2 (Cell Signaling) overnight at 4°C. After washing in TBST,
the blots were incubated with horseradish peroxidase-conjugated secondary antibody
(Pierce), diluted 1:2000 in blocking solution, for one hour at room temperature. The
blots were then incubated with the ECL chemiluminescent substrate (Amersham) and
exposed to film according to manufacturer’s instructions.

In-gel Kinase Assay
Soluble cell lysates were collected and quantified as described above for immunoblot
analysis. Ten to fifteen micrograms of total protein was diluted in 2X SDS-PAGE
sample buffer and separated on 10 % polyacrylamide gels containing 0.1 mg/ml fulllength myelin basic protein (MBP) (Sigma). After electrophoresis, gels were washed in
20% 2-propanol, 50 mM Tris-HCl, pH 8.0, for one hour at room temperature to remove
the SDS. The gels were then equilibrated in 50 mM Tris-HCl, pH 8.0, 5 mM 2mercaptoethanol for one hour. After equilibration the proteins were denatured in 6 M
guanidine HCl, 50 mM Tris-HCl, pH 8.0, 5 mM 2-mercaptoethanol. The proteins were
refolded overnight by incubation in 50 mM Tris-HCl, pH 8.0, 0.04% Tween-20, 5 mM 294

mercaptoethanol with gentle shaking at 4°C. The following day, gels were incubated in
reaction buffer (50 mM HEPES, pH 8.0, 2 mM DTT, 10 mM MgCl2). Phosphorylation
of MBP was carried out at 25°C for one hour in reaction buffer supplemented with 0.5
mM EGTA, 2 µM cAMP-dependent protein kinase inhibitor (Sigma), 40 µM ATP, and
100 µCi [γ-32P]ATP (ICN). The reaction was stopped by immersing the gel in 5%
trichloroacetic acid (TCA) containing 10 mM sodium pyrophosphate. Gels were washed
an additional 5-10 times in 5% TCA, dried, exposed to film, and quantitated by scanning
densitometry using the UN-SCAN-IT software program (Silk Scientific Inc.).

H1 Kinase Assay
The assay for CDC2/CYCLIN-B1 (MPF) activity was performed as described by
Cobb et al. (1999a). MPF was immunoprecipitated from soluble cell lysates by
incubating 50 µg of protein lysate with 25 µg p13suc1 (p13) agarose beads (UpState
Biotechnology) for 2 hours at 4°C. The p13 beads were collected by centrifugation at
14,000 rpm for 20 seconds. The beads were washed in lysis buffer (50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 0.1% NP-40, 50 mM NaF, 1 mM Na3VO4, 1 mM DTT, 1 mM PMSF,
10 µg/ml soybean trypsin inhibitor, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 5 µg/ml
DNase) three times before finally being washed in assay buffer (25 mM MOPS, pH 7.2,
60 mM β-glycerol phosphate, 30 mM p-nitrophenylphosphate (Sigma), 15 mM EGTA,
15 mM MgCl2, 100 µM Na3VO4, 1mM DTT, 1 mM PMSF). The beads were then
resuspended in 20 µl of assay buffer. Duplicate samples were used for the histone H1
kinase assay. Five microliters of the p13 agarose beads were added to 20 µl of assay
buffer containing 100 µg/ml histone H1 (Sigma), 15 µM ATP, 1 µg/ml cAMP-dependent
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protein kinase inhibitor (Sigma) and 100 µCi [γ-32P]ATP (ICN). The reactions were
incubated for one hour at 37°C and stopped by addition of 25 µl 2X SDS-PAGE sample
buffer. The samples were resolved on a 10% SDS-PAGE gel followed by
autoradiography. The results were quantitated by using the UN-SCAN-IT software
program (Silk Scientific Inc.).

Immunofluorescence Localization
Spermatocytes isolated from germ cell preparations were embedded in fibrin-clots as
previously described (Eaker et al., 2001). Briefly, isolated germ cells were brought to a
concentration of 25x106 cells/ml. On a Gold Seal Rite-On Fluorescent Antibody slide
(Fisher Scientific) 1.5 µl of the cell suspension was added to 3 µl of fibrinogen
(Calbiochem, 10 mg/ml), prepared fresh prior to use. To the cell/fibrinogen mix, 2.5 µl
of thrombin (Sigma, 250 units) was added and the clots were allowed to form. Following
clot formation the spermatocytes were fixed in 4% paraformaldehyde, washed in 0.2%
Triton X-100, followed by blocking in PBS/10% goat serum (Gibco BRL) for 30
minutes. Primary antibodies detecting SYCP3 (Eaker et al., 2001), β-tubulin (ICN),
ERK1 (Santa Cruz Biotechnology), ERK2 (Santa Cruz Biotechnology) and PhosphoMAPK (New England Biolabs) were diluted in PBS/10% goat serum and incubated
overnight in a humidified chamber. Rhodamine- and flourescein-conjugated secondary
antibodies (Pierce), diluted 1:500, were added and incubated for 2-3 hours in the dark.
Coverslips were mounted with ProLong Antifade (Molecular Probes) containing DAPI to
visualize the DNA. Control slides were incubated with either pre-immune sera or with
secondary antibodies only in order to determine antibody specificity.
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Immunolocalization was observed with an Olympus epifluorescence microscope. All
images were captured to Adobe PhotoShop using a Hamamatsu color 3CCD camera.

Air-dried Chromosome Preparations
Chromosome condensation was assessed by a modification of the Evans procedure
(Evans et al., 1964). Briefly, 2.5x106 cultured cells were pooled and pelleted by
centrifugation. After washing in 2.2% sodium citrate the cells were allowed to swell in a
1% sodium citrate solution. After this hypotonic swelling, the spermatocytes were fixed
in a 3:1 absolute ethanol/glacial acetic acid solution. The cells were dropped onto a
prewarmed slide and allowed to air dry. The air-dried cell preparations were then stained
with Giemsa (Sigma) and scored for the presence of MI figures.
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CHAPTER III
RESULTS

1. Expression and Localization Analysis
ERK1 and ERK2 Expression in Spermatogenic Cells
To assess the possibility of roles for ERK1 and/or ERK2 throughout spermatogenesis,
expression levels of these kinases were investigated by Western blot analysis. Pooled
populations of germ cells (purity of at least 80%) were isolated over a BSA gradient from
mice of various ages and were subsequently used for Western blotting. The ERK1
antibody, which recognizes both the 44-kDa ERK1 protein and the 42-kDa ERK2 protein
with a similar level of specificity, was used to investigate the expression of ERK1 and
ERK2. As shown in Figure 2A, the 44-kDa ERK1 is expressed in all cells examined,
from the mitotic spermatogonia to the haploid round spermatids, with little to no change
in expression levels. A similar level of expression was also observed for ERK2, except
in residual bodies where the level of ERK2 decreased slightly. The antibody against the
ERK2 protein, which demonstrates a higher specificity for ERK2 over ERK1, produced
similar results (data not shown).
Since ERK1 and ERK2 are expressed at similar levels in the mitotic spermatogonia,
meiotic spermatocytes, and post-meiotic germ cells, little information as to their role in
male meiosis can be inferred, except that they apparently are not regulated at the level of
protein expression. Phosphorylation of ERK1 and ERK2, possibly in a cell cycle
dependent manner, could be a factor governing regulation of their activity during meiosis.
An antibody detecting phospho-MAPK was used to investigate the phosphorylation
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Figure 2: Analysis of ERK1/2 expression throughout spermatogenesis. (A) Cellspecific Western blot probed with an anti-ERK1 antibody. ERK1 and ERK2 are
expressed at similar levels in mitotic spermatogonia, meiotic prophase spermatocytes and
post-meiotic germ cells. (B) Western blot analysis of the active (phosphorylated) forms
of ERK1/2. ERK1/2 are phosphorylated in mitotic spermatogonia and
leptotene/zygotene spermatocytes. Phosphorylation levels decline in early pachytene
spermatocytes, while pachytene spermatocytes have no detectable levels of
phosphorylation. G-spermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early
pachytene spermatocytes, P-pachytene spermatocytes, RS-round spermatids, RB-residual
bodies, A-adult whole testis.
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(activation) status of ERK1/2 throughout spermatogenesis (Figure 2B). Phosphorylation
(activation) of ERK1/2 is the highest in mitotic spermatogonia, suggesting that ERK1/2
may play a role in the spermatogonial divisions. Phosphorylation levels decline slightly
in leptotene/zygotene spermatocytes, and no phosphorylation was observed in pachytene
spermatocytes. This is similar to a previously reported pattern of ERK1/2 expression and
phosphorylation (Lu et al., 1999; Sette et al., 1999).

Localization of ERK1, ERK2 and the Phosphorylated Forms of ERK1/2
To provide further evidence for a role of the MAPKs during spermatogenesis, indirect
immunofluorescence microscopy was used to monitor the localization of the kinases
throughout meiotic prophase. Localization patterns of ERK1 and ERK2 were similar in
fibrin-clot embedded spermatocytes. ERK1 and ERK2 during the first meiotic prophase
were found throughout the chromatin of spermatocytes (Figure 3A). Due to the lack of a
suitable nuclear envelope marker, it was not possible to determine if ERK1/2 localization
was confined to the nucleus or extended into the cytoplasm. When spermatocytes enter
the first meiotic division a dramatic re-localization of ERK1 and ERK2 was observed.
There was a shift from the very general and non-specific pattern of prophase to
localization solely within the meiotic spindle at MI, confirmed by co-localization with βtubulin (Figure 3B). Interestingly, ERK1 and ERK2 are not present in the chromosomes
at MI, confirmed by DAPI staining (Figure 3C).
In contrast to this localization pattern for ERK1 and ERK2 throughout meiotic
prophase, the phosphorylated (active) forms of the MAPKs were not observed until
diplonema (Figure 4A). At diplonema, the phosphorylated forms of the MAPKs were
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Figure 3: Localization of ERK1 and ERK2 in fibrin-clot embedded spermatocytes. (A)
ERK1 and ERK2 in pachytene and diplotene spermatocytes exhibit a non-specific pattern
of localization throughout the nucleus of the cell. At metaphase I, ERK1 and ERK2
associate with the meiotic spindle. (B) Localization of ERK1 and ERK2 in the meiotic
spindle was confirmed by co-localization with β-tubulin. (C) ERK1 and ERK2 are
excluded from the chromosomes at metaphase I, revealed by DAPI co-staining. Cell
stages were determined by structure of the lateral elements of the synaptonemal complex,
assessed by the SYCP3 antibody. Scale bar = 10 µm.
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Figure 4: Localization of the phosphorylated, active forms of ERK1/2 in fibrin-clot
embedded spermatocytes. (A) Pachytene spermatocytes have no detectable levels of
active ERK1/2. The active MAPKs appeared in diplotene and metaphase I
spermatocytes. (B) There is no specific localization of the active MAPKs on the meiotic
spindle, which is visualized by β-tubulin localization. Additionally, the active MAPKs
were excluded from the chromosomes at metaphase I, as observed for ERK1 and ERK2.
Cell stage was determined by localization of SYCP3. Scale bar = 10 µm.
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detected throughout the entire chromatin area, and as the cells entered the division phase,
the intensity of the staining increased. These phosphorylated forms were not readily
detectable in the meiotic spindle at MI (Figure 4B), in contrast to the results with ERK1
and ERK2 antibodies. However, it is possible that the intensity and generality of
antibody localization at MI masks localization to the meiotic spindle. Similar to the
localization of ERK1 and ERK2, no co-localization of phosphorylated forms with DAPI
was detected at MI, suggesting that both the active and inactive forms of ERK1 and
ERK2 do not associate directly with the chromosomes (Figure 4B). This observation is
in contrast to localization of the phosphorylated forms of the MAPKs to metaphase I
chromosomes by Di Agostino et al. (2002).
These data, particularly the localization of phospho-MAPKs in diplotene and MI
spermatocytes, and the re-localization of ERK1 and ERK2 to the meiotic spindle, suggest
the possibility of a role(s) for the MAPKs in the G2/MI transition of meiosis. Relocalization to the meiotic spindle at MI implies that the MAPKs may be involved or are
necessary for spindle assembly and/or maintenance. Moreover, these data suggest that
ERK1 and ERK2 are not regulated by their expression levels, but rather by their
phosphorylation status.

Expression of MEK1, MEK2, and the Phosphorylated Forms of MEK1/2 Throughout
Spermatogenesis
Since ERK1 and ERK2 localization suggested they could regulate the meiotic division
the expression levels of their activating kinases, MEK1 and MEK2, was examined in
spermatogenic cells by Western blotting (Figure 5A). Analysis of purified populations of
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Figure 5: Analysis of MEK1 and MEK2 expression throughout spermatogenesis. (A)
Cell-specific Western blot probed with an anti-MEK1 antibody. MEK1 expression is the
most abundant in mitotic spermatogonia and leptotene/zygotene spermatocytes.
Expression decreases in early pachytene spermatocytes and is barely detectable at
pachynema. (B) MEK2, unlike MEK1, is expressed at consistent levels through
pachynema, with a decrease in expression observed in post-meiotic germ cells. (C) The
phosphorylation status of MEK1/2 was assessed with a phospho-specific MEK1/2
antibody. Phosphorylation was detected in the mitotic spermatogonia and early meiotic
prophase cells. The phosphorylated forms were not observed in pachytene spermatocytes
or round spermatids. G-spermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early
pachytene spermatocytes, P-pachytene spermatocytes, RS-round spermatids, RB-residual
bodies, A-adult whole testis.
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germ cells revealed that the 45-kDa MEK1 is expressed only in the mitotic
spermatogonia and in the earliest meiotic prophase spermatocytes in the testis.
Interestingly, MEK1 is not expressed in pachytene spermatocytes. In contrast to the
limited expression of MEK1 during spermatogenesis, MEK2 is expressed in the mitotic
spermatogonia, in all stages of meiotic prophase spermatocytes, and in post-meiotic cells
(Figure 5B).
The phosphorylated forms of MEK1/2 (Figure 5C) exhibited an expression pattern
identical to that observed for the phosphorylated forms of the MAPKs (Figure 2B).
MEK1/2 is phosphorylated primarily in the mitotic spermatogonia and in the
leptotene/zygotene spermatocytes. A lesser degree of phosphorylation was detected in
early pachytene spermatocytes. However, by mid-late pachynema the phosphorylated
forms of MEK1/2 were no longer detected.
Consistent expression patterns were observed in germ cell lysates, prepared
throughout pubertal development (Figure 6). Expression of both the phosphorylated
forms of MEK1/2 and ERK1/2 is highest in germ cells isolated from 7 and 12-day old
mice, when the mitotic spermatogonia and leptotene/zygotene spermatocytes,
respectively, are present. A decrease in the phosphorylation levels was observed at 17
and 22 days of age, when pachytene spermatocytes first appear.
The phosphorylation of both MEK1/2 and ERK1/2 at the same developmental period,
suggests that perhaps MEK1/2 could govern phosphorylation and activation of ERK1/2
in early stages of germ cell meiosis.
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Figure 6: Developmental expression analysis of the MAPK kinases, MEK1/2, and the
MAPKs, ERK1/2, during spermatogenesis. (A) MEK1 is expressed in the earliest stages
of spermatogenesis from day 7 to 17, at which time a slight decrease in expression is
observed. Little to no expression was observed at day 22. In contrast to MEK1, MEK2
expression does not change and is expressed from day 7 to adult. Analysis of the
phosphorylation status of MEK1/2, using a phospho-specific antibody, revealed
phosphorylation at day 7, when the mitotic spermatogonia are the most abundant, up until
day 22, when pachytene spermatocytes are most abundant. (B) Developmental
expression analysis of the MAPKs during spermatogenesis with an anti-ERK1 antibody.
The MAPKs are expressed at constant levels from day 7 to adult. Unlike expression of
ERK1/2, phosphorylation is detected only during the earliest developmental stages, and is
barely detectable at day 22.
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2. Activation of the MAPK Pathway
Activation of the MAPKs in Response to OA Treatment
Expression and localization patterns of ERK1/2 and MEK1/2 suggest that they might
be involved in the spermatocyte’s G2/MI transition. Study of this transition has been
facilitated by the discovery that treatment of pachytene spermatocytes with the
phosphatase inhibitor OA results in a precocious and rapid chromosome condensation to
a typical MI configuration (Wiltshire et al., 1995). Thus by treatment of spermatocytes
with OA, the meiotic G2/MI transition can, at least in part, be mimicked and the players
involved studied with the caveat that OA may abrogate normal regulatory steps.
As shown in Figure 2B, pachytene spermatocytes have almost undetectable levels of
phosphorylated ERK1/2, suggesting that the MAPKs do not play a regulatory role at this
stage of meiosis. To determine if ERK1/2 are important for the OA-induced meiotic
division phase, pachytene spermatocytes were cultured in the presence of 5 µM OA for
varying amounts of time. The phosphorylation status of ERK1/2 was monitored by
Western blotting with an anti-phospho-MAPK antibody. As shown in Figure 7A, cells
cultured with the solvent alone showed no increase in the phosphorylation status of
ERK1/2, while those cultured in the presence of OA showed an increase in
phosphorylation in a time-dependent manner. This demonstrates the phosphorylation of
ERK1/2 is a direct result of OA treatment and not of cell culture, and suggests the
MAPKs, ERK1/2, could play a role in the OA-induced meiotic G2/MI transition.
To directly demonstrate enzymatic activities of ERK1/2, an in-gel kinase assay was
performed. The MAPK substrate, MBP, was co-polymerized in a polyacrylamide gel.
Time-dependent OA-induced activation of the MAPKs was observed by an increase in
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Figure 7: Analysis of MAPK activity after 5 µM OA treatment. (A) Immunoblot
analysis of pachytene spermatocytes treated with EtOH over a course of 8 hours showed
little to no effect on the phosphorylation status of ERK1/2. After treatment with OA,
ERK1/2 phosphorylation increased in a time-dependent manner, with maximum
activation observed after 4 hours of treatment. (B) In-gel kinase assay demonstrating
the activation of the MAPKs in response to OA treatment. Pachytene spermatocytes
cultured in the presence of EtOH have very small, but detectable amounts of the active
MAPKs present. Treatment with OA results in an increase in MBP phosphorylation,
demonstrating MAPK activation. C-EtOH treated, OA-5 µM OA treated, P-no culture or
treatment.
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intensity of the phosphorylated substrate (Figure 7B). Shown are the results of two
independent experiments. In contrast to the preferential activation of ERK1 observed by
Sette et al. (1999) in OA treated pachytene spermatocytes, no activation of ERK1 was
observed in the in-gel kinase assay. However, phosphorylation of ERK1 was detected on
an immunoblot after OA treatment (Figure 7A).

Treatment of Pachytene Spermatocytes with the MEK1/2 Inhibitor U0126
The phosphorylation of the MAPKs after OA treatment, together with their
localization in spermatocytes, suggests ERK1/2 could function at the meiotic G2/MI
transition. Previously, Sette et al. (1999) and Di Agostino et al. (2002) tested this
hypothesis using two different MEK1/2 inhibitors, PD98059 and U0126. They reported
that long-term exposure to either inhibitor resulted in inhibition of OA-induced MI
chromosome condensation, implying that ERK1/2, are required for this process (Sette et
al., 1999; Di Agostino et al., 2002). Curiously, these results were not replicated in our
analysis of PD98059 (Cobb et al., unpublished) and U0126 (below) treatment of
pachytene spermatocytes.
Since previous studies have shown that pre-treatment with 10 µM U0126 for fifteen
minutes effectively blocked ERK1/2 activation (Favata et al., 1998), spermatocytes were
pre-treated with 10-40 µM U0126 for 30 minutes prior to OA treatment. The in-gel
kinase assay showed no inhibition of MAPK activity under these conditions (data not
shown). To ensure that OA was not overriding inhibitory effects of U0126, the
concentration of OA was reduced from 5 µM to 0.5 µM. However, these conditions
likewise did not lead to inhibition of either MAPK activation or chromosome
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condensation in OA treated spermatocytes (data not shown). Next, the length of
exposure to U0126 was increased from 30 minutes to overnight, similar to that in
previous studies (Sette et al., 1999; Di Agostino et al., 2002). Again there was no
apparent decrease in MAPK activation observed by the in-gel kinase assay (Figure 8A).
Air-dried chromosome preparations were scored for the presence of MI chromosome
configurations (Figure 8B). Among spermatocytes treated with 10 µM U0126 followed
by OA treatment, 25.9% exhibited condensed chromosomes in an MI configuration,
while a similar percentage (26.3%) of spermatocytes pre-treated with 40 µM U0126 also
exhibited condensed chromosomes. These frequencies of spermatocytes with condensed
chromosomes after pre-treatment with U0126 are similar to those treated with OA alone
(28.6%). Thus long exposure to U0126 did not inhibit OA-induced chromosome
condensation or MAPK activation, implying either that the target MEK is not accessible
or that spermatocytes activate MAPKs by a MEK-independent pathway.
The disparity between these results and those of others (Di Agostino et al., 2002) led
us to ensure that growth factors in the culture medium were not overriding the effects of
U0126. Thus, the 5% fetal bovine serum normally used in our cell culture media was
replaced with 0.5% BSA to more closely mimic the culture conditions reported by Sette
et al. (1999) and Di Agostino et al. (2002). Additionally, other minor modifications were
made to the experimental design to more closely replicate the previously published
conditions (Sette et al., 1999; Di Agostino et al., 2002), including reducing cell
concentration to 1x106 cells/ml (instead of 2.5x106 cells/ml) and dissolving OA in
DMSO, not EtOH. Spermatocytes were cultured overnight in either the serum-rich (5%
FBS) or serum-starved (0.5% BSA) media with 10 µM U0126 (Di Agostino et al., 2002)
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Figure 8: Assessment of MAPK activity and chromosome condensation in pachytene
spermatocytes treated with the MEK1/2 inhibitor, U0126. (A) An in-gel kinase assay
demonstrating activity of the MAPKs after an overnight pre-treatment with 10 µM or 40
µM

U0126 followed by 0.5 µM OA for 5 hours. Treatment with 0.5 µM OA resulted in

an approximate 4-fold increase in activation of ERK1/2 while pre-treatment with the
MEK1/2 inhibitor, U0126, had no effect on ERK1/2 activation. (B) Pachytene
spermatocytes were scored for the presence of bivalent MI chromosomes after overnight
treatment with U0126. Treatment with U0126 did not prevent OA-induced chromosome
condensation.
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and then treated with 0.5 µM OA. Analysis of air-dried chromosome preparations
revealed no substantive difference between the number of U0126 treated spermatocytes
with condensed MI chromosomes compared to those cultured without inhibitor (Figure
9). Interestingly, there was a small effect of medium on the OA-induced chromosome
condensation. The frequency of spermatocytes with condensed chromosomes was higher
among those cultured in serum-rich (5% FBS) media than among those cultured in the
serum-starved (0.5% BSA) media. Thus these nutritional conditions may affect ability of
spermatocytes to respond to OA, but they do not affect response to U0126 treatment.

U0126 Prevents MAPK Activation in Spermatogonia and Early Meiotic Prophase
Spermatocytes
The lack of U0126 effect on OA-induced chromosome condensation and MAPK
activation by pachytene spermatocytes, coupled with low expression of MEK1 in
pachytene spermatocytes, led us to test the role of MEK1/2 in ERK1/2 activation during
the earliest stages of spermatogenesis. Germ cells were isolated from 7, 12, 17, and 22day old mice and were cultured with either 10 µM or 40 µM U0126.
Phosphorylation/activation of ERK1 and ERK2 after treatment was assessed by Western
blot analysis using a phospho-specific MAPK antibody. In 7-day old mice, when the
mitotic spermatogonia are the most abundant, and in 12-day old mice when the
leptotene/zygotene spermatocytes are abundant U0126 treatment inhibited endogenous
levels of MAPK activation (Figure 10A, B). While some phosphorylation was still
detected after treatment with 10 µM U0126, phosphorylation was completely inhibited
after 40 µM U0126 for as little as two hours.
119

Figure 9: Assessment of chromosome condensation after culture in serum-rich (5% FBS)
or serum-starved (0.5% BSA) media. Pachytene spermatocytes were cultured overnight
in the presence of 10 µM U0126 followed by 0.5 µM OA treatment. Spermatocytes were
scored for condensation of bivalent MI chromosomes. Among spermatocytes cultured in
serum-rich media, a higher frequency (28.6% + 6.5) exhibited condensed chromosomes
than among those in serum-starved media (19.3% + 3.3). Treatment with U0126 did not
affect chromosome condensation, compared to OA treated controls without U0126.
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Figure 10: Inhibition of endogenous levels of MAPK activity by U0126 treatment. (A
and B) Overnight treatment of mixed germ cell preparations from 7-day (A) and 12-day
(B) old mice with 40 µM U0126 prevented ERK1/2 activation, monitored by Western
analysis using a phospho-specific MAPK antibody. A two hour treatment was sufficient
to completely inhibit activation. (C and D) MAPK activity is inhibited upon treatment
with 10 µM U0126 in 17-day (C) and 22-day (D) old mice. Serum, present in the culture
media, did not stimulate activation. U0124 was unable to inhibit activation in all
instances.
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U0126 treatment of germ cells isolated from 17 and 22-day old mice, ages at which
early pachytene and pachytene spermatocytes, respectively, become abundant, also
resulted in inhibition of MAPK activation, even at the lower concentration of 10 µM
(Figure 10C, D). Treatment of cultured germ cells with the inactive analog of U0126,
U0124, had no effect on MAPK inhibition. Additionally, no increase in phosphorylation
was detected in germ cells that were cultured in serum-rich media over those that were
not cultured, supporting previous observations that serum does not affect the activation
status of ERK1/2 in cultured spermatocytes (Figure 7).
Taken together these results suggest that at least in mitotically dividing spermatogonia
and in early meiotic prophase spermatocytes U0126 is able to prevent endogenous levels
of MAPK activation, demonstrating that U0126 is permeable to spermatocytes and that
MEK1/2 is responsible for MAPK activation during the earliest stages of
spermatogenesis.

Treatment with the CDC2 Inhibitor, Butyrolactone I, Prevents MAPK Activation
The activation of the MAPKs has been shown to be a prerequisite for MPF activation
in Xenopus oocytes (Kosako et al., 1994; Gotoh et al., 1995; Gotoh and Nishida, 1995;
Kosako et al., 1996), but this regulation is not conserved among species (Verlhac et al.,
1993; Verlhac et al., 1994; Araki et al., 1996; Choi et al., 1996; Verlhac et al., 1996;
Kajiura-Kobayashi et al., 2000; Yoshida et al., 2000). Recent evidence gathered from
studies investigating interplay of MPF and the MAPKs in rat oocytes suggest that MPF
activation is a prerequisite for MAPK activation, contradictory to that required by
Xenopus oocytes (Josefsberg et al., 2003).
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To explore the regulatory relationships between MPF and the MAPKs during
spermatogenesis, pachytene spermatocytes were cultured in the presence of the CDC2
inhibitor, butyrolactone I (Kitagawa et al., 1993). Previously, butyrolactone I was shown
to inhibit OA-induced MPF activation and chromosome condensation in pachytene
spermatocytes (Cobb et al., 1999b). Butyrolactone I treatment resulted in a six-fold
reduction in the number of spermatocytes able to condense bivalent chromosomes in
response to OA treatment (data not shown). H1 kinase assays confirmed the previously
reported inhibition of MPF (data not shown). Furthermore, butyrolactone I inhibited the
MBP-phosphorylation activity that is the hallmark of active MAPKs, suggesting that
MPF may regulate the activation of ERK1/2 during spermatogenesis (data not shown).
To ensure that butyrolactone I was not directly inhibiting MAPK activity, pachytene
spermatocytes were treated with varying concentrations (10-100 µM) of butyrolactone I.
A dose-dependent inhibition of chromatin condensation was observed (Figure 11). At a
concentration of 10 µM, approximately 50% of the spermatocytes condensed bivalent
chromosomes in response to OA treatment, while at 100 µM, only 7% did so.
Additionally, a dose-dependent decrease in H1 kinase activity was observed (Figure
12A). A similar inhibition of MAPK activity was observed. (Figure 12B). The decrease
in MAPK activity mirrored the decrease observed in MPF activity, suggesting that
spermatocytes may possess a novel regulatory pathway leading to the activation of the
MAPKs.
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Figure 11: Assessment of chromosome condensation in response to treatment with the
CDC2 inhibitor, butyrolactone I. (A) Approximately 80% of spermatocytes condensed
bivalent MI chromosomes in response to OA treatment. However, upon pre-treatment
with butyrolactone I the number of spermatocytes that condensed bivalent chromosomes
decreased with increasing concentrations of inhibitor. (B) Air-dried chromosome
preparations demonstrating the inability of spermatocytes to condense bivalent
chromosomes after pre-treatment with butyrolactone I. Scale bar = 10 µm.
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Figure 12: Analysis of H1 kinase and MAPK activity after butyrolactone I treatment.
(A) Histone H1 kinase assay showing inhibition of MPF upon treatment with the CDC2
inhibitor, butyrolactone I. Treatment of spermatocytes with 5 µM OA resulted in a 4-fold
increase in MPF activity over that of EtOH treated controls. However, pre-treatment
with butyrolactone I, prior to OA stimulation, resulted in a dose-dependent inhibition of
MPF activity. (B) An in-gel kinase assay demonstrating the inhibition of MAPK activity
in response to treatment with butyrolactone I. OA treatment results in the activation of
the MAPKs, enabling them to phosphorylate the substrate MBP. Upon pre-treatment
with butyrolactone I, the ability of the MAPKs to phosphorylate MBP decreases with
increasing concentrations of inhibitor.
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3. Other Regulators
MOS is Not Required for MAPK Activation During Spermatogenesis
Generation of mice deficient for the c-mos protooncogene demonstrated the
importance of this regulatory molecule in activation of the MAPKs and in maintaining
metaphase II arrest in oocytes (Colledge et al., 1994; Hashimoto et al., 1994; Araki et al.,
1996; Choi et al., 1996; Verlhac et al., 1996). The lack of a visible phenotype or
impairment in spermatogenesis suggests that although MOS is required for the meiotic
G2/MI transition in the female, it is dispensable in the male. Nevertheless, the Mos
knockout is a useful tool for investigating the necessity of ERK1/2 and the signal
transduction pathway governing their activation both in vivo and in vitro. Analysis of
mixed germ cell preparations from Mos-deficient animals suggests that, unlike oocytes,
spermatocytes can activate MAPKs in the absence of MOS. MI spermatocytes embedded
in fibrin-clot preparations showed positive immunoreactivity with an anti-phosphoMAPK antibody (Figure 13). Localization was excluded from the chromosomes and was
identical to that observed for control heterozygous littermates. Isolated pachytene
spermatocytes from Mos-deficient animals, when cultured in the presence of 5 µM OA,
condensed bivalent MI chromosomes. These results, and the normal spermatogenic
phenotypes of Mos-deficient males, demonstrate that MOS is not required for the meiotic
G2/MI transition in vivo or in vitro and that it is not a necessary component for regulating
chromosome condensation in spermatocytes (Figure 14A). Analysis of MAPK activation
(by in-gel kinase assays) after OA treatment showed that activation of the MAPKs was
not dependent upon MOS (Figure 14B), supported also by the immunofluorescence
analysis (Figure 13). The MAPKs were activated at similar levels to their heterozygous
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Figure 13: Localization of the phosphorylated forms of the MAPKs in fibrin-clot
embedded spermatocytes from Mos-/- mice. No evidence of nuclear or cytoplasmic
localization of the active/phosphorylated forms of the MAPKs was found in pachytene
spermatocytes from either the heterozygous (A) or knockout mice (B). However, upon
entry into the division phase, active/phosphorylated MAPKs were detected in the nucleus
of both heterozygous (A) and knockout spermatocytes (B). Antigen was largely excluded
from the chromosomes, but otherwise detected throughout the nucleus. Cell stage was
determined by localization of SYCP3. Scale bar = 10 µm.
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Figure 14: Analysis of Mos-deficient spermatocytes to undergo the OA-induced G2/MI
transition. (A) Air-dried chromosome preparations demonstrating the ability of Mos-/spermatocytes to condense bivalent chromosomes in response to OA treatment. Scale bar
= 10 µm. (B) In-gel kinase assay demonstrating the ability of Mos-/- spermatocytes to
activate the MAPKs after OA treatment. Both heterozygous and knockout spermatocytes
have very little endogenous MAPK activity, as observed by little MBP phosphorylation.
However, a dramatic increase in the phosphorylation status of MBP is observed in
heterozygous and knockout spermatocytes upon treatment with OA, implying activation
of the MAPKs.
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littermate controls upon OA stimulation. The results suggest that unlike the situation in
females, MOS is not necessary for MAPK activation during spermatogenesis, revealing
differences in the regulation and the signaling molecules required by both the male and
female for successful transition out of prophase and into the division phase.

CDC25C is Not Required for OA-Induced Activation of MPF
A continuing area of interest is how OA treatment stimulates a precocious metaphase
I-like state in pachytene spermatocytes and how closely this state mimics the naturally
occurring transition. Previous hypotheses suggested that the CDC25C protein
phosphatase was involved in regulating the artificial G2/MI transition (Cobb et al.,
1999a). Generation of fertile male mice deficient for Cdc25C demonstrated that the
CDC25C phosphatase is not required for the meiotic G2/MI transition in vivo and/or that
other signaling molecules can compensate for its loss (Chen et al., 2001).
To determine whether CDC25C is necessary for the OA-induced transition, Cdc25C
mutant spermatocytes were isolated and treated with OA. This in vitro analysis
demonstrated the dispensability of CDC25C in the OA-induced G2/MI transition.
Cdcd25C-/-spermatocytes condensed bivalent metaphase I chromosomes at a frequency
equivalent to their heterozygous littermate controls after OA treatment (Figure 15).
Furthermore the mutant spermatocytes activated MPF after OA treatment (Figure 16A),
providing evidence that spermatocytes posses an alternative, CDC25C-independent,
pathway for MPF activation. The activation status of the MAPKs is also not influenced
by the absence of CDC25C, as mutant spermatocytes activated the MAPKs at similar
levels as heterozygous controls in response to OA treatment (Figure 16B).
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Figure 15: Assessment of chromosome condensation in Cdc25C-/- spermatocytes. (A)
Pachytene spermatocytes from heterozygous and knockout mice were scored for the
presence of bivalent MI chromosomes after treatment with 5 µM OA. Cdc25C-/spermatocytes condensed bivalent chromosomes (74.5% + 5.6) at the same frequency as
their heterozygous littermate controls (77.2% + 5.1). (B) Condensed bivalent MI
chromosomes in response to OA treatment. Scale bar = 10 µm.
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Figure 16: Analysis of histone H1 and MAPK activity in Cdc25C-/- spermatocytes. (A)
Histone H1 kinase assay demonstrating the ability of Cdc25C-/- spermatocytes to activate
MPF in response to OA treatment. Heterozygous and knockout spermatocytes treated
with 5 µM OA for 6 hours activated MPF to two times the level of spermatocytes treated
with EtOH alone. (B) In-gel kinase assay showing the activation of the MAPKs in
response to treatment with 5 µM OA. Spermatocytes cultured in the presence of EtOH
have small, but detectable levels of active MAPKs. Upon treatment with OA an
equivalent increase in the activity level of the MAPKs is observed in both the
heterozygous and knockout spermatocytes.
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CHAPTER IV
DISCUSSION

Prior to this study very little was known of the signaling molecules required by the
spermatocyte for successful completion of the G2/MI transition. Previous studies
demonstrated the necessity of MPF in regulating the precocious metaphase I-like state
induced by OA, but there still remain many unanswered questions (Cobb et al., 1999b).
We have furthered our understanding of the G2/MI transition in spermatocytes taking
advantage of both chemical inhibitors and mutant mouse models. The results presented
here suggest that spermatocytes have an alternate pathway leading to activation of the
MAPKs, independent of both MOS and MEK1/2. Spermatocytes isolated from Mosdeficient animals demonstrated MAPK activity in vivo and in vitro, and treatment of
spermatocytes with the MEK1/2 inhibitor, U0126, failed to inhibit OA-induced ERK1/2
activity. However, treatment with the CDC2 inhibitor, butyrolactone I, successfully
prevented ERK1/2 activation suggesting that MPF may directly or indirectly regulate
MAPK activation during spermatogenesis, revealing a novel regulatory pathway.
Additionally, the regulation of MPF was investigated using a mouse model deficient for
the CDC25C protein. Cdc25C-/- spermatocytes condensed bivalent chromosomes and
activated MPF in response to OA treatment, demonstrating that spermatocytes possess a
CDC25C-independent pathway leading to MPF activation. Taken together, these studies
reveal that MOS or CDC25C is not needed for the OA-induced progression into the
division phase and that unlike oocytes, spermatocytes do not require MOS or MEK1/2 for
activation of ERK1/2.
140

The OA-Induced Meiotic G2/MI Transition
Analysis of the G2/MI transition during spermatogenesis has been difficult, primarily
because the relevant cell types, the late meiotic prophase and MI spermatocytes, are
present in such low numbers and lack distinguishing characteristics needed for isolation.
By using a short-term culture system coupled by treatment with OA, a type 1 and 2A
phosphatase inhibitor, this problem has in part been circumvented. An initial report
demonstrated that OA treatment of pachytene spermatocytes induced premature
condensation of bivalent metaphase I-like chromosomes (Handel et al., 1995). Closer
analysis demonstrated that OA treatment also prompted nuclear envelope breakdown and
synaptonemal complex disassembly, suggesting that treatment with OA overrides a cell
cycle checkpoint that keeps pachytene spermatocytes in a lengthy meiotic prophase
(Wiltshire et al., 1995). Coincident with these events an increase in H1 kinase activity,
an indicator of MPF activity, was observed upon OA treatment (Chapman and
Wolgemuth, 1994; Wiltshire et al., 1995; Cobb et al., 1999b).
MPF, composed of CDC2 and CYCLIN B1, has been identified as a key regulatory
molecule in both mitotic cell divisions and meiotic divisions in oocytes. The necessity of
MPF activity in regulating the OA-induced transition has previously been demonstrated
for spermatocytes (Cobb et al., 1999b). Treatment of isolated pachytene spermatocytes
with butyrolactone I, a CDC2 inhibitor, prevented OA-induced MPF activation and
condensation of bivalent MI chromosomes, identifying a key regulatory player in the
spermatocyte’s meiotic G2/MI transition. Although CDC2 and CYCLIN B1 are present
in early meiotic prophase, leptotene and zygotene spermatocytes fail to activate MPF and
condense bivalent MI chromosomes in response to OA treatment (Cobb et al., 1999a),
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demonstrating that OA does not directly activate MPF and that at least one other
regulatory molecule is involved in governing the transition from prophase to division in
spermatocytes.

CDC25C is Not Required for MPF Activation in the OA-Induced Transition
Spermatocytes acquire competence at mid-pachynema, paralleled by the accumulation
of histone H1t and CDC25C (Cobb et al., 1999a). Members of the Cdc25 family are
dual specificity protein phosphatases that control the activation of the cyclin-dependent
protein kinases (CDKs), including the CDC2 subunit of MPF (Nurse 1990; Pines and
Hunter, 1990; Norbury et al., 1991).
A model for OA-induced MPF activation has been proposed based on the acquisition
of competence and appearance of CDC25C. It has been suggested that OA treatment
may inhibit the type 2A protein phosphatases (PP2A) that act on CDC25C, resulting in its
inactivation (Clarke et al., 1993; Cobb et al., 1999a). When the PP2As are inhibited
upon OA treatment, CDC25C remains active, which in turn stimulates MPF activity
leading to the precocious transition. However, the generation of a Cdc25C-deficient
mouse model with no apparent phenotype has called into question the necessity of this
regulatory molecule in the in vivo transition (Chen et al., 2001) and has allowed us to test
the necessity of CDC25C in the in vitro transition induced by OA.
Cdc25C-/- spermatocytes responded to OA treatment, condensing bivalent MI
chromosomes at the same frequency, as did their heterozygous littermate controls (Figure
15). Additionally, MPF and the MAPKs were active in Cdc25C-deficient spermatocytes
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(Figure 16), demonstrating that CDC25C is not involved and/or that other regulatory
molecules, perhaps either CDC25A or CDC25B, can compensate for its loss.
Evidence from oocytes deficient for Cdc25B suggests that Cdc25C may not be
involved in the regulation of MPF at the meiotic G2/MI transition. Cdc25B-/- oocytes
arrest at prophase and fail to undergo the G2/MI transition, possibly because of their low
levels of MPF activity (Lincoln et al., 2002). On the other hand, Cdc25B-/- male mice are
fertile and have no apparent phenotype, revealing yet again another difference in the
regulatory molecules required by oocytes and spermatocytes for completion of the G2/MI
transition. Expression analysis indicates that Cdc25B is expressed predominantly in the
somatic cells of the testis, possibly explaining the observed sexual dimorphism (Wu and
Wolgemuth, 1995). Cdc25A, however, is expressed in diplotene spermatocytes, putting it
at the right place and time for acting in the G2/MI transition (Mizoguchi and Kim, 1997),
although mutational analysis is needed to determine a more precise role for CDC25A.

Identifying the Kinase(s) Involved in the OA-Induced Meiotic G2/MI Transition
Besides not knowing the kinase(s) responsible for the OA-induced activation of MPF,
the kinase(s) involved in regulating synaptonemal complex disassembly and histone H3
phosphorylation, both of which occur in response to OA treatment, remain unidentified.
Butyrolactone I treatment revealed that MPF was not involved in regulating either of
these processes in OA treated pachytene spermatocytes (Cobb et al., 1999b).
The phosphorylation of histone H3 also occurred in incompetent leptotene and
zygotene spermatocytes upon OA treatment (Cobb et al., 1999a), further demonstrating
that the phosphorylation of histone H3 is not sufficient for chromosome condensation and
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the kinase(s) responsible for histone H3 phosphorylation are not associated with
acquisition of competence, and therefore must be expressed and active early in meiotic
prophase.
The MAPKs, previously identified as important regulators of the meiotic divisions in
oocytes, are present in leptotene and zygotene spermatocytes (Figure 2A) (Lu et al.,
1999; Sette et al., 1999), making them prime candidates for regulating the G2/MI
transition during spermatogenesis.

ERK1/ 2 are Active at the Meiotic G2/MI Transition In Vivo and In Vitro during
Spermatogenesis
Immunolocalization data revealed a role for the MAPKs, ERK1/2, at the G2/MI
transition during spermatogenesis. Localization was very general in meiotic prophase
spermatocytes, but as the spermatocyte reached MI a dramatic re-localization to the
meiotic spindle was observed, suggesting a possible role for these proteins in spindle
assembly and/or maintenance (Figure 3). Unfortunately, the low abundance of naturally
occurring MI spermatocytes and the necessity of type 2A phosphatases for spindle
assembly, which are inhibited upon OA treatment, prevents further detailed analysis of
ERK1/2 in these processes in vivo or in vitro (Alexandre et al., 1991; Tournebize et al.,
1997; Lu et al., 2002). However, the MAPKs have been previously shown to be essential
for spindle assembly and maintenance in both mitotic cells and meiotically dividing
oocytes, further supporting a conserved role for ERK1/2 in these processes during
spermatogenesis (Gotoh et al., 1991; Verlhac et al., 1993; Araki et al., 1996; Verlhac et
al., 1996; Guadagno and Ferrell, 1998; Gordo et al., 2001; Horne and Guadagno, 2003).
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Even more importantly in implicating the MAPKs in the natural progression from
meiotic prophase to the division phase was the localization of the phosphorylated, or
active forms, of the MAPKs (Figure 4A). Localization was observed only in diplotene
and metaphase I spermatocytes, placing active MAPKs at the right place and time for
acting in the spermatocyte’s G2/MI transition. However, in our studies neither the active
or inactive forms of the MAPKs localized to meiotic MI chromosomes (Figure 4B), in
contrast to a previously published report that documented localization of the
phosphorylated forms directly on meiotic chromosomes (Di Agostino et al., 2002). One
possible reason for the discrepancy may be the type of preparation used for
immunofluorescence localization. For our analysis spermatocytes were embedded in
fibrin-clots, a type of preparation that retains the soluble proteins of the cell. In contrast,
Di Agostino et al. (2002) used a preparation in which the cells were lysed in a hypotonic
solution, disrupting cell integrity and possibly resulting in re-localization or loss of
cytoplasmic proteins. Because the integrity of the cell is not compromised before
fixation, the fibrin-clot method of preparation is probably more representative of actual
structural localization in the spermatocyte. Furthermore, our results are consistent with
immunolocalization of both the inactive and active forms of the MAPKs during the
meiotic divisions in oocytes; namely, with no direct localization to the chromosomes
reported, and localization confined primarily to the microtubules and microtubule
organizing centers (MTOCs) of the developing spindle (Verlhac et al., 1993; Hatch and
Capco, 2001; Lu et al., 2002; Fan et al., 2003).
In addition to their role in the naturally occurring transition, the MAPKs have also
been implicated in the precocious transition induced by OA. Treatment of mammalian
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oocytes results in ERK1/2 activation, leading to the resumption of meiosis and germinal
vesicle breakdown in incompetent, prophase-arrested oocytes (Zernicka-Goetz et al.,
1997; Sun et al., 1999a; Sun et al., 1999b; de Vantéry Arrighi et al., 2000; Lu et al.,
2001; Sun et al., 2002). Similarly activation of the MAPKs occurs in pachytene
spermatocytes after OA treatment with evidence suggesting a role for these proteins in
chromosome condensation or spindle assembly (Figure 7) (Sette et al., 1999; Di Agostino
et al., 2002).
A previously published report suggested that OA-induced MAPK activation in
spermatocytes preferentially involves ERK1 rather than ERK2 (Sette et al., 1999).
However, our analysis suggests the opposite. When a phospho-specific MAPK antibody
was used to analyze the phosphorylation status of ERK1/2 after OA treatment, the 42kDa band, which corresponds to ERK2, increased in intensity compared to that of ERK1,
suggesting increased levels of ERK2 phosphorylation (Figure 7A). Results from in-gel
assays also support the preferential activation of ERK2, as only one band was detected,
which corresponded to the size of ERK2 (Figure 7B). The preferential activation of
ERK1 reported by Sette et al. (1999) was determined by immunoprecipitating ERK1 and
ERK2 from OA treated cell lysates and testing the levels of activity found in the
immunoprecipitates. However, due to the cross-reactivity of both antibodies the actual
amount of activity contributed by ERK1 or ERK2 alone cannot be determined from this
approach. A previous study, using an approach similar to ours, reported that the majority
of MAPK activity observed in bovine oocytes was due to activation of ERK2 (Fissore et
al., 1996), however, other studies have observed equivalent levels of ERK1 and ERK2
activity in oocytes (Kubelka et al., 2000).
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Activation of the MAPKs During Spermatogenesis is Not Dependent on the MOS
Protein
The MAPK kinase kinase, MOS, was previously shown to be necessary for
maintaining metaphase II arrest in oocytes and for activation of the MAPKs (Colledge et
al., 1994; Hashimoto et al., 1994). However, our analysis reveals spermatocytes
deficient for Mos activate the MAPKs, ERK1/2, at similar levels to their heterozygous
controls. The phosphorylated forms of the MAPKs are found in diplotene and MI
spermatocytes naturally undergoing the G2/MI transition (Figure 13). Additionally,
Mos-deficient spermatocytes activate the MAPKs and condense bivalent MI
chromosomes in response to OA treatment (Figure 14), implying that the OA-induced,
precocious transition mimics the natural occurring transition in that MOS is not required
for either one.
The finding that Mos-deficient spermatocytes activate ERK1/2 suggests that
spermatocytes have some mechanism for which to compensate for the loss of MOS. The
MAPK kinase kinase, RAF, may compensate for the loss of MOS, but injection of
constitutively active forms of RAF into Mos-deficient mouse oocytes could not recover
MAPK activity (Verlhac et al., 2000). Another possibility is that spermatocyte’s have a
novel, unidentified regulatory molecule or pathway responsible for MAPK regulation.
To test the possibility of a novel regulatory pathway, the necessity of the ERK-activating
kinases, MEK1/2, were tested using the MEK1/2 inhibitor, U0126.
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Activation of the MAPKs Occurs Through a MEK-Independent Mechanism in
Pachytene Spermatocytes
Before this study the expression of MEK1 and MEK2, the MAPK kinases that are
responsible for ERK1/2 activation in other systems and the target of U0126 (Matsuda et
al., 1992; Pelech and Sanghera, 1992; Davis, 1993; Favata et al., 1998), had previously
not been investigated during spermatogenesis. Analysis of protein expression revealed
that MEK1 was expressed predominantly in mitotic spermatogonia and in
leptotene/zygotene spermatocytes (Figure 5A). In contrast to MEK1, MEK2 was
expressed throughout spermatogenesis in all cell types examined (Figure 5B). Therefore,
if the MEK pathway leading to MAPK activation operates in pachytene spermatocytes,
activation must occur by MEK2, since MEK1 is not expressed at the right time or place
to be involved in the in vivo or in vitro transition.
The phosphorylation/activation status of MEK1/2 (Figure 5C) was found to be very
similar to that of ERK1/2 (Figure 2B), suggesting that MEK1/2 could control ERK1/2
activity in the initial stages of spermatogenesis. Regulation of ERK1/2 by MEK1/2 was
confirmed by treatment with U0126, culture for only two hours in the presence of the
inhibitor, was sufficient to completely block endogenous levels of MAPK activity (Figure
10), implying that in the mitotically dividing spermatogonia and in the leptotene/zygotene
spermatocytes the pathway leading to MAPK activation is similar to that reported for
somatic cell divisions and for meiotic cell divisions in the female.
Treatment of pachytene spermatocytes with the MEK1/2 inhibitor, U0126, did not
inhibit OA-induced activation of the MAPKs and chromosome condensation (Figure 8),
in contrast to previously published studies (Sette et al., 1999; Di Agostino et al., 2002).
148

Different experimental approaches were taken to address this discrepancy. The first
addressed culture conditions, particularly whether serum could stimulate the activity
levels of the MAPKs. Initial results indicated that serum by itself did not stimulate
MAPK activity, since activity levels in pachytene spermatocytes cultured in the presence
of 5% FBS were similar to those in cells that were not cultured (Figure 7). To rule out
the possibility that serum could affect the spermatocyte’s ability to respond to OA,
spermatocytes were cultured in a serum-starved (0.5% BSA) media similar to that used
by Sette et al. (1999) and Di Agostino et al. (2002). Serum-starvation resulted in a slight
decrease in the overall number of spermatocytes exhibiting condensation of bivalent MI
chromosomes in response to OA treatment (Figure 9). Therefore, serum is not essential
for the OA-induced precocious G2/MI transition, in agreement with Sette et al. (1999).
Additionally, the culture media had no effect on the spermatocyte’s response to U0126
treatment. No reduction in the number of MI spermatocytes was observed after U0126
treatment, when compared to the OA treated controls cultured in the same media.
The only point at which U0126 treatment had any effect on progression to MI was
when spermatocytes were treated with a diluted stock of U0126, increasing the total
amount of DMSO present in the culture media (data not shown). The inhibition of
chromosome condensation matched that reported by Di Agostino et al. (2002). The
effect was observed only when spermatocytes were cultured in the serum-starved media,
suggesting nutritional requirements and DMSO concentration together may compromise
the spermatocyte’s response to OA.
Although differences in experimental culture conditions may in part explain the
discrepancy in results reported by our laboratory and those of others, it is not a totally
149

satisfactory explanation because U0126 inhibition of chromosome condensation occurred
only under extreme culture conditions (excessive pre-treatment, poor nutrition). Since
these conditions are not normally encountered by spermatocytes, the response is not
physiological.
Perhaps even more importantly, the inhibition of endogenous MAPK activity in early
meiotic prophase spermatocytes by U0126 treatment demonstrates spermatogenic cell
permeability to the inhibitor. Prior to this observation, a primary concern about lack of
U0126 inhibition was that the inhibitor might not penetrate the spermatocyte’s cell
membrane. Given that early spermatocytes are permeable to U0126, it seem likely that
mid-late pachytene spermatocytes also take up the inhibitor.
Expression analysis puts MEK2 at the right time and place for activating the MAPKs.
However, lack of inhibition by U0126 under physiological conditions suggests that
MAPK activation can occur through a MEK-independent mechanism in spermatocytes.
This idea is supported by the recent generation and analysis of Mek2-deficient mice,
which are fertile (Bélanger et al., 2003).

Butyrolactone I Treatment Results in MAPK Inhibition
Additional support for a MEK-independent mechanism comes from analysis of
spermatocytes treated with the CDC2 inhibitor, butyrolactone I. Butyrolactone I
inhibited OA-induced bivalent chromosome condensation (Figure 11) (Cobb et al.,
1999b), accompanied by a dose-dependent inactivation of the MAPKs (Figure 12B),
further supporting a MEK-independent mechanism of activation in pachytene
spermatocytes.
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Treatment of pig and bovine oocytes with butyrolactone I also inhibited MPF and
MAPK activity (Kubelka et al., 2000; Kubelka et al., 2002). OA treatment of bovine
oocytes did not overcome the inhibitory effects of butyrolactone I, as observed here for
pachytene spermatocytes. Bovine oocytes failed to undergo germinal vesicle breakdown,
and both MPF and the MAPKs were inactive. Porcine oocytes, on the other hand,
responded differently; germinal vesicle breakdown occurred and the MAPKs were active
after OA treatment. However, MPF activity remained inhibited, suggesting that porcine
oocytes do not require MPF and/or that the MAPKs can compensate stimulating germinal
vesicle breakdown. This also demonstrates that regulation of meiotic divisions is not
conserved even between female mammalian species.
However, unlike the inhibition of chromosome condensation observed in
spermatocytes, butyrolactone I had no effect on chromosome condensation in either pig
or bovine oocytes (Kubelka et al., 2000; Kubelka et al., 2002) demonstrating that MPF
and the MAPKs are not necessary for chromosome condensation and that chromosome
condensation is not necessary for progression into the division phase in oocytes. This
further demonstrates sexual dimorphism in the regulation of events and the players
involved in the G2/MI transition.

Conclusion
This study focusing on the regulation of the MAPKs, ERK1/2, has provided insight
into the regulation of the meiotic G2/MI transition in spermatocytes. Evidence suggests
that spermatocytes have an alternate pathway leading to MAPK activation that is not
dependent on the MAPK kinase kinase, MOS, on the MAPK kinase, MEK1/2, or on the
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CDC25C phosphatase. Instead, MAPK activation seems to be controlled by MPF during
spermatogenesis. Regulation of MAPK activity by MPF is not novel, however, the
manner in which this regulation occurs in the spermatocyte may be. A previous report
demonstrated that in rat oocytes MPF controlled MAPK activation by stabilizing the Mos
transcript (Josefsberg et al., 2003). Studies conducted in our laboratory and those of
others have shown that MOS is not required during the G2/MI transition in vitro or in
vivo (Colledge et al., 1994; Hashimoto et al., 1994), suggesting that perhaps MPF
directly interacts with the MAPKs and/or controls the regulation of an unidentified
regulatory molecule that influences the activation state of the MAPKs.
One possibility that we cannot exclude is that OA treatment may abrogate normal
regulatory steps of the G2/MI transition. Treatment with OA could directly activate the
MAPKs by directly inhibiting their dephosphorylation by PP2As, known to directly act
on the MAPKs (Zhou et al., 2002), explaining the lack of inhibition by U0126 treatment.
However, we believe that this is unlikely given that OA treatment cannot override the
inhibitory effects of butyrolactone I on MAPK activity. Evidence thus far, the activation
of the MAPKs and the dispensability of MOS and CDC25C in vitro, suggests that the
transition induced by OA mimics that of the naturally occurring transition.
These studies are only a starting point for understanding the requirements for the
G2/MI transition in spermatocytes. Data presented here supports previous observations
that the players and events regulating meiosis are not conserved between males and
females. These experiments lay the foundation for future investigations of the regulatory
pathways controlling the G2/MI transition during spermatogenesis, both in vivo and in
vitro. Of particular interest is determining how MPF activation governs the
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regulation/activation of the MAPKs and how these molecules act to regulate chromosome
condensation. It is possible that MPF may regulate chromosome condensation through
phosphorylation of the 13S condensin complex. CDC2 was previously shown to
phosphorylate the 13S condensin complex in Xenopus and humans in vitro (Kimura et
al., 1998; Kimura et al., 2001). Another area of interest is the role(s) of ERK1/2 in
regulating the events of early meiotic prophase. The inhibition of ERK1/2 activity levels
in early meiotic spermatocytes by treatment with U0126 provides a tool for investigating
their roles in the initial stages of spermatogenesis.
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PART IV

COLLABORATIONS ON CHROMOSOMAL PROTEINS*

*Analysis of the mei1 mutation was done in collaboration with Dr. John Schimenti at The
Jackson Laboratory in Bar Harbor, Maine. Portions of this work were published as Libby
BJ, De La Fuente R, O’Brien MJ, Wigglesworth K, Cobb J, Inselman A, Eaker S, Handel
MA, Eppig JJ, Schimenti JC. 2002. The mouse meiotic mutation mei1 disrupts
chromosome synapsis with sexually dimorphic consequences for meiotic progression.
Dev. Biol. 242: 174-187.
Analysis of the H1a, H1t-deficient mouse model was done in collaboration with Dr.
Arthur Skoultchi at The Albert Einstein College of Medicine, Bronx, NY.
Analysis of RAD21, REC8, SMC1, SMC1β, and SMC3 expression was done in
collaboration with Drs. Huiling Xu and Michael McKay at The Peter MacCallum Cancer
Centre, East Melbourne, Australia.

161

ABSTRACT

Meiosis is a complex cell division process accompanied by dramatic rearrangements
in nuclear architecture and chromosome structure. Many chromosomal rearrangements
and modifications occur during the extended meiotic prophase, which is characterized by
homologous chromosome pairing and recombination. Many of the proteins involved in
these processes were originally identified and characterized in yeast, prior to their
discovery in mammalian systems. Here we followed the expression levels (by Northern
and Western blotting) of the mouse homologs of the S. pombe genes, rad21 and rec8.
Rad21 mRNA expression was detected in both the mitotic spermatogonia and early
meiotic prophase spermatocytes. At pachynema a smaller 2.2 kb transcript was
observed; this transcript was expressed exclusively in mid-prophase and post-meiotic
cells. A single Rec8 transcript was detected throughout spermatogenesis, expressed
predominantly in pachytene spermatocytes and in post-meiotic germ cells, coincident
with protein expression. The expression of RAD21 and REC8 suggests the possibility of
a conserved role for these proteins in maintaining meiotic chromosome cohesion.
Expression analysis of the structural maintenance of chromosomes (SMC) proteins,
responsible for maintaining chromosome cohesion and known to interact with RAD21
and REC8, were also determined.
Expression and localization studies are important for inferring regulatory
relationships, but do not directly test gene function. Recent advances in knockout
technology have allowed mutant mouse models deficient for a single gene to be created.
Phenotypic analysis of these mutant models allows the determination of gene function.
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The role of the testis-specific linker histone H1t was previously tested in this manner.
Upon analysis, H1t-deficient mice had no detectable phenotype, suggesting that histone
H1t is not necessary or that another histone H1 subtype can compensate for its loss. To
test this possibility H1a-/-, H1t-/- double mutants, deficient for both linker histones, were
generated; we report here on their phenotype. Immunolocalization of synaptonemal
complex and recombination-related proteins revealed no obvious defects in the mutant
spermatocyte’s ability to synapse homologous chromosomes or repair recombinationrelated double-strand breaks. H1a, H1t- deficient spermatocytes condensed bivalent
metaphase I-like chromosomes in response to OA treatment with no morphological
defects. The results suggest that the linker histones, H1a and H1t, are not required for
completion of meiotic prophase and division phase events.
Important to our complete understanding of meiotic processes is identification of the
key players involved. Much of our knowledge about genes involved in mammalian
meiosis has derived from mutational analysis in yeast. Although these studies have been
fruitful, there are shortcomings. Therefore, a powerful new approach to identifying novel
meiosis-specific genes in mammals is by using phenotype-driven mutagenesis screens.
We report here the characterization of meiosis defective 1 (mei1) the first meiotic
mutation derived by a novel-embryonic stem cell-based chemical mutagenesis screen in
mice. Analysis of mei1/mei1 spermatocytes revealed an early meiotic prophase arrest, at
zygonema, exhibiting failure of homologous chromosome synapsis. Notably, RAD51
failed to associate with meiotic chromosomes, despite evidence for the presence of
chromosomal breaks. Analysis of the mei1 phenotype, in conjunction with mapping
studies, suggests that mei1 is a novel meiotic gene.
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CHAPTER I
INTRODUCTION

In this part, Part IV, we discuss our contributions to ongoing collaborative projects
analyzing various aspects of chromosomal remodeling.

Proteins Involved in Establishing/Maintaining Meiotic Chromosome Cohesion
Spermatogenesis is characterized by dramatic rearrangements in chromosome
structure, namely homologous chromosome synapsis and recombination. These
processes are essential for maintaining chromosome pairing/synapsis until the first
meiotic division when homologous chromosomes are segregated. The highly conserved
structural maintenance of chromosomes (SMC) family of proteins, members of which
compromise a large multi-protein complex known as cohesion, are also involved in
maintaining chromosome pairing/synapsis (for review see Hirano, 1999; Strunnikov and
Jessberger, 1999; Cobbe and Heck, 2000; Hirano, 2000; van Heemst and Heyting, 2000;
Petronczki et al., 2003; Uhlmann, 2003).
Sister chromatid cohesion is established during replication in both mitosis and meiosis;
however, the maintenance/regulation of cohesion varies between the two cell division
processes. During mitosis in yeast, the cohesion complex is tightly associated with
chromosomes until the metaphase to anaphase transition (Michaelis et al., 1997; Toth et
al., 1999) when proteolytic cleavage by the cysteine protease separase releases the
cohesion complex from the chromosomes, allowing for their accurate segregation
(Uhlmann et al., 2000). Meiotic cohesion must differ from mitotic cohesion to prevent
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premature separation of sister chromatids at the first meiotic division. Cohesion is lost
along the lengths of the sister chromatids in a manner similar to that observed during
mitosis, but cohesion is maintained at the centromeric regions and persists until anaphase
II (Klein et al., 1999; Watanabe and Nurse, 1999). However, it is not understood how
centromeric cohesion is maintained into metaphase II (for review see Petronczki et al.,
2003).
Differences in the regulation of chromosome cohesion may in part be attributed to
mitosis- and meiosis-specific variants of the cohesion complex. Both mitotic and meiotic
cohesion complexes consist of SMC1 and SMC3 heterodimers. The SMC heterodimers
interact with the non-SMC subunits RAD21 and SCC3 during mitosis (for review see
Jessberger, 2002), whereas in meiotic cohesion complexes RAD21 is replaced with
REC8, and SCC3 with STAG3 (Parisi et al., 1999; Prieto et al., 2001; Lee et al., 2002;
Prieto et al., 2002). Additionally a meiosis specific variant of SMC1, SMC1β, has
recently been identified (Revenkova et al., 2001). To date SMC3 is the only cohesion
complex member that has no meiosis-specific variant.
Studies have documented the timing and appearance of members of the meiotic
cohesion complex throughout spermatogenesis. SMC1, SMC3, SMC1β, and REC8
localize along the length of the synaptonemal complex and have been shown to interact
with the synaptonemal complex proteins, SYCP2 and SYCP3 (Eijpe et al., 2000; Pelttari
et al., 2001; Revenkova et al., 2001; Eijpe et al., 2003; Lee et al., 2003). Although
immunolocalization studies have been conducted, analysis of total RNA and protein
levels throughout spermatogenesis have not been determined. Here we report on a
collaboration with Drs. Huiling Xu and Michael McKay at The Peter MacCallum Cancer
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Centre in East Melbourne, Australia to determine cell-specific expression of members of
the cohesion complex.

Characterization of H1a, H1t-Deficient Spermatocytes
The histones are a family of basic proteins that are involved in organizing the DNA in
nuclei into a compact structure known as chromatin. There are four classes of histones,
known as the core histones, and a class of linker H1 histones. In mice the class of linker
histones are the most divergent with seven H1 subtypes having been identified (Lennox
and Cohen, 1983; Lennox and Cohen, 1984), including a testis-specific subtype (H1t).
By using homologous recombination, Dr. Arthur Skoultchi at The Albert Einstein
College of Medicine created a mouse knockout of the testis-specific subtype of histone
H1 (Lin et al., 2000). Analysis of the mice homozygous for the mutation showed that
they were indeed lacking histone H1t in their germ cells, but showed no detectable defect
in spermatogenesis and were fertile. Closer analysis of chromatin structure revealed that
although histone H1t was absent, the germ cells still had a normal ratio of H1 to
nucleosomes, indicating that other H1 subtypes may have been deposited in the
chromatin in place of H1t and can presumably compensate for most or all of H1t’s
functions. More specifically, the histone H1a subtype was found to account for 50% of
the histone H1 present in germ cells of H1t null mice. Therefore, a mouse model with
two null alleles, one for H1a and for H1t, was created. The H1a-/-, H1t-/- double mutants
are also fertile, but have an altered chromatin structure with an H1 to nucleosome ratio
about 75% of normal. Here we report on the analysis of H1a-/-, H1t-/- mutant
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spermatocytes for defects in homologous chromosome pairing, recombination, and
chromosome condensation.

Analysis of the mei1 Meiotic Mutation
The genetic control of mammalian meiosis is not well understood, in part due to lack
of meiotic mutations. To date most of the meiotic mutations have derived from studies
using homologous recombination technology in embryonic stem cells to create mouse
models deficient for a single gene. Many of the genes chosen for mutation in the mouse
have orthologs in yeast and have known roles in meiosis. While exploitation of crossspecies homology has been productive, there are pitfalls and shortcomings to this
approach. First, there are genes important for meiosis in yeast that either do not exist or
have not been identified in mammals. Secondly, knockouts of mouse genes can produce
phenotypes that are vastly different from the meiotic defects caused by deficiency of the
yeast orthologs. Finally, it is likely that there are many genes that are required for proper
completion of meiosis in mammals that are not present in yeast, due in part to the
complexity and sexual dimorphism of gametogenesis in mammals. These issues can be
solved, at least in part, by a phenotype-driven approach to identify genes that affect
meiosis in a mammalian model.
We report here on the characterization of meiosis defective 1 (mei1) a meiotic
mutation derived by a novel embryonic stem cell-based chemical mutagenesis screen
(Munroe et al., 2000). Characterization was done in collaboration with Dr. John
Schimenti at The Jackson Laboratory in Bar Harbor, Maine.
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CHAPTER II
MATERIALS AND METHODS

Animals, Germ Cell Isolation, and Spermatocyte Enrichment
ICR mice were obtained from Harlan (Indianapolis, IN), while those carrying the mei1
and H1a, H1t targeted mutations were generously provided by Drs. John Schimenti (The
Jackson Laboratory, Bar Harbor, ME) and Arthur Skoultchi (The Albert Einstein College
of Medicine, Bronx, NY), respectively. XXSxr mice were from a breeding stock
maintained in our laboratory. All mice were housed under 14 hour light/10 hour dark
photoperiods at constant temperature (21°C), with free access to standard laboratory chow
and water.
Enriched fractions of germ cells were isolated from ICR male mice of varying ages.
Spermatogonial cell populations were collected from 8-day old mice, leptotene/zygotene
and early pachytene spermatocytes were collected from 17-day old mice, while pachytene
spermatocytes, round spermatids, and residual bodies were collected from mice at least 8
weeks of age. Following cervical dislocation the testes were removed, detunicated, and
digested in 0.5 mg/ml collagenase (Sigma) in Krebs-Ringer bicarbonate (KRB) buffer at
32°C for 20 minutes, followed by a subsequent digestion in 0.5 mg/ml trypsin (Sigma) at
32°C for 13 minutes. After digestion, the germ cells were filtered through a 53 or 80 µm
Nitex filter and washed three times in KRB containing 0.5% bovine serum albumin
(BSA) (Sigma). The single-cell suspension was sedimented at unit gravity through a 24% BSA gradient, as described previously by Bellvé et al. (1993). The gradient was
collected after two and a half hours at a rate of 10 mls/45 seconds. Fractions were
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assessed for morphology and purity by light microscopy using Nomarski optics. Purified
populations of germ cells were subsequently used for Western blot and Northern blot
analysis as described below.
Mixed germ cell populations were obtained from mei1 and H1a, H1t-deficient male
mice. The testes were removed, detunicated, and enzymatically digested as described
above. Germ cells were cultured or processed for surface-spread preparations, described
below.

Cell Culture and Treatment
Isolated testicular germ cells from H1a, H1t-deficient mice were washed and
resuspended in HEPES-buffered MEMα culture medium (Sigma) supplemented with 25
mM NaHCO3, 5% v/v fetal bovine serum (FBS) (Gibco BRL), 20 mM sodium lactate, 59
µg/ml

penicillin, 100 µg/ml streptomycin, as previously described (Handel et al., 1995).

The cells were plated at a concentration of 2.5x106 cells/ml in 4-well Nunclon dishes
(Fisher Scientific). The cells were cultured at 32°C in a humified atmosphere with 5%
CO2. After a two hour recovery period, the cells were treated with 5 µM OA
(Calbiochem), dissolved at 244 µM in 100% ethanol, for 4 hours. After treatment cells
were harvested and processed for cytological analysis as described below.

Purification of RNA and Northern Blot Analysis
Total RNA was extracted from purified spermatogenic fractions or whole testes using
the guanidinium thiocyanate-phenol-chloroform method of Chomczynski and Sacchi
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(1987). RNA was quantified spectrophotometrically by measuring absorbance at 260 nm
and 280 nm; extracted RNA was stored at -80°C.
Equivalent amounts (10 µg) of total RNA were separated by denaturing agarose gel
electrophoresis, following standard methods, and transferred to Duralon-UV membranes
(Stratagene) by capillary action. The blots were UV cross-linked and stored at -20°C
until use.
The cDNA probes for Rad21, Rec8, Smc1β, Smc1 and Smc3 (generously provided by
Drs. Huiling Xu and Michael McKay, The Peter MacCallum Cancer Centre, East
Melbourne, Australia) were labeled using the MegaPrime Random Prime Labeling Kit
(Amersham). Blots were hybridized in 0.5 M Na2HPO4, 1 mM EDTA, 7% SDS, 1%
BSA overnight at 60°C. After hybridization, blots were washed briefly in 2X SSC at
room temperature, followed by two washes each in 2X SSC + 0.5% SDS and in 0.5X
SSC + 0.5% SDS for 30 minutes at 60°C. Blots were exposed to X-ray film (Kodak
Biomax MS) at -80°C with an intensifying screen for an empirically determined length of
time.

Immunoblot Analysis
Preparation of cell lysates was performed as previously described (Cobb et al., 1999).
Proteins were separated by SDS-PAGE and transferred to nitrocellulose using a BioRad
semi-dry transfer apparatus. The blots were blocked in 10% nonfat milk dissolved in
Tris-buffered saline/0.1% Tween-20 (TBST) for one hour at room temperature. The
blots were probed with anti-RAD21 or anti-REC8 antibodies (generously provided by
Drs. Huiling Xu and Michael McKay, The Peter MacCallum Cancer Centre, East
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Melbourne, Australia) overnight at 4°C. After washing in TBST, the blots were incubated
with horseradish peroxidase-conjugated secondary antibody (Pierce), diluted 1:2000 in
blocking solution, for one hour at room temperature. The blots were incubated with the
ECL chemiluminescent substrate (Amersham) and exposed to film according to
manufacturer’s instructions.

Surface-Spread Chromatin Preparations
Surface-spread chromatin preparations for visualization of the synaptonemal complex
were performed as previously described (Cobb et al., 1997). Briefly, germ cells were
fixed in 2% paraformaldehyde/0.3% SDS before being spread onto Shandon slides
(Shandon Lippshaw, Pittsburgh, PA). The slides were allowed to air dry and then
blocked in wash buffer (0.3% BSA, 1.0% goat serum in PBS) before being processed for
immunolocalization.

Antibodies and Immunolocalization
Primary antibodies used included those that recognized the following proteins:
SYCP3 (Eaker et al., 2001), phospho-H2AX (UpState Biotechnology), H1t (described in
Part II), phospho-histone H3 (UpState Biotechnology), and RAD51 (Oncogene).
Following overnight incubation with primary antibody, the slides were incubated with
rhodamine- or flourescein-conjugated secondary antibodies (Pierce). Coverslips were
mounted using ProLong Antifade (Molecular Probes) containing DAPI to visualize the
DNA. Control slides were incubated with either pre-immune sera or with secondary
antibodies only in order to determine antibody specificity. Immunolocalization was
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observed with an Olympus epifluorescence microscope. All images were captured to
Adobe PhotoShop using a Hamamatsu color 3CCD camera.

Air-dried Chromosome Preparations
Chromosome condensation was assessed by a modification of the Evans procedure
(Evans et al., 1964). Briefly, 2.5x106 cultured cells were pooled and pelleted by
centrifugation. After washing in 2.2% sodium citrate the cells were allowed to swell in a
1% sodium citrate solution. After this hypotonic swelling, the spermatocytes were fixed
in a 3:1 absolute ethanol/glacial acetic acid solution. The cells were dropped onto a
prewarmed slide and allowed to air dry. The air-dried cell preparations were then stained
with Giemsa (Sigma) and scored for the presence of MI figures.
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CHAPTER III
RESULTS AND DISCUSSION

Cell-Specific Expression Analysis of Proteins Involved in Maintaining Meiotic
Chromosome Cohesion
1. Expression of SMC Family Members
Immunofluorescence analyses have previously documented the localization of
cohesion complex proteins throughout meiosis (Eijpe et al., 2000; Pelttari et al., 2001;
Revenkova et al., 2001; Eijpe et al., 2003; Lee et al., 2003); however, total levels of
RNA and protein had not previously been determined. Therefore, we examined cellspecific expression of members of the cohesion complex. Northern analysis of Smc1
(Figure 1A) and Smc3 (Figure 1B) revealed similar expression patterns of transcripts
from the two genes. Expression was highest in mitotic spermatogonia and decreased in
leptotene and zygotene spermatocytes. Expression levels remained fairly constant
throughout meiotic prophase and increased in post-meiotic round spermatids. No
expression was detected in the residual bodies. Expression was also observed in the germ
cell-deficient XXSxr mice. In contrast to Smc1 and Smc3, Smc1β was detected only in
mid-late meiotic prophase spermatocytes and post-meiotic germ cells (Figure 1C). No
transcript was detected in XXSxr mice that lack meiotic germ cells further demonstrating
Smc1β is meiosis specific.
The expression of Smc1 and Smc3 transcripts is consistent with reported
immunolocalization patterns (Eijpe et al., 2000). SMC1 and SMC3 localized to meiotic
prophase spermatocytes, becoming readily apparent along the lengths of the
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Figure 1: Northern blot analysis of Smc1, Smc3, and Smc1β expression. (A) Smc1
transcript levels were highest in mitotic spermatogonia and decreased in spermatocytes.
Increased transcripts levels were detected in the post-meiotic round spermatids. Analysis
of Smc3 expression throughout spermatogenesis produced similar results (B). (C)
Expression analysis of the meiotic-specific variant Smc1β. Smc1β transcripts were
present in early pachytene spermatocytes, pachytene spermatocytes and round
spermatids. No expression was detected in germ cell-deficient XXSxr mice. (D)
Expression of the Actin transcript was monitored to control for equal loading. Gspermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early pachytene
spermatocytes, P-pachytene spermatocytes, RS-round spermatids, RB-residual bodies, Aadult whole testis, XXSxr-whole testis from germ cell-deficient mice.
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synaptonemal complex at zygonema. Although immunolocalization data indicated
decreased localization of SMC1 and SMC3 in the post-meiotic round spermatids,
Northern analysis showed an increase in transcript levels, suggesting an alternate role for
these proteins.
Similarly, the expression of Smc1β transcript was fairly consistent with
immunolocalization data (Revenkova et al., 2001). SMC1β localized to the axial
elements of the synaptonemal complex at zygonema, although transcript levels were not
readily detectable until early pachynema. High transcript levels were also detected in
post-meiotic round spermatids, again suggestive of an alternate role other than in
maintaining cohesion. However, Western analysis should be done to verify the presence
of protein in post-meiotic germ cells.

2. Expression of the Non-SMC Subunits of the Cohesion Complex
In contrast to a previous published report (Eijpe et al., 2000), Rad21 transcript was
expressed throughout spermatogenesis, with a 3.1 kb transcript observed in mitotic
spermatogonia and meiotic spermatocytes (Figure 2A). Transcript levels remained fairly
constant until pachynema when the levels were dramatically reduced; this was coincident
with the appearance of a 2.2 kb transcript. The 2.2 kb transcript is the only one detected
in post-meiotic round spermatids and residual bodies. Western blot analysis of RAD21
identified a 120-kDa protein in spermatogonia, leptotene/zygotene, early pachytene and
pachytene spermatocytes and in the round spermatids (Figure 2B). Expression appeared
the highest in spermatogonia and leptotene/zygotene spermatocytes, decreasing slightly
in early pachytene spermatocytes.
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Figure 2: Cell-specific analysis of RAD21 expression. (A) A 3.1 kb Rad21 transcript
was detected in mitotic spermatogonia and in leptotene/zygotene and early pachytene
spermatocytes. In pachytene spermatocytes a 2.2 kb transcript was detected along with
the 3.1 kb transcript. The 2.2 kb transcript was predominant in post-meiotic germ cells.
(B) Western blot analysis of RAD21 expression. A 120-kDa band, corresponding to
RAD21, was detected throughout spermatogenesis. Lower molecular weight bands,
corresponding to the molecular weight of REC8, were also detected. G-spermatogonia,
L/Z-leptotene/zygotene spermatocytes, EP-early pachytene spermatocytes, P-pachytene
spermatocytes, RS-round spermatids, RB-residual bodies, T-whole testis, XXSxr-whole
testis from germ cell-deficient mice.
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Northern blot analysis of Rec8 showed expression in all germ cell stages examined
(Figure 3A). Expression was seen in spermatogonia and leptotene/zygotene
spermatocytes at a comparable level. Expression levels dropped in early pachynema, but
increased greatly in pachynema. Expression further increased in round spermatids and
dropped slightly in residual bodies. Low levels of expression were also seen in XXSxr
mice. Analysis of protein expression revealed two and possibly three protein variants
(Figure 3B). A 65-kDa band was first detected in early pachytene spermatocytes and
expression remained constant through to the residual body stage. A lower band,
approximately 45-kDa in size, was detected in residual bodies. This was also detected in
adult whole testis at a lower level of expression. A lower band was also present on the
Western blot, with an expression profile identical to the 65-kDa variant.
Taken together the expression of RAD21 and REC8 throughout spermatogenesis
suggests that both proteins are essential for maintaining chromatid cohesion. The
expression of RAD21 is consistent with its recently observed localization pattern during
spermatogenesis. RAD21 was localized to the lateral elements of the synaptonemal
complex during meiotic prophase, and also on the centromeres, a pattern that persisted
until anaphase II (Xu and McKay, personal communication).
Currently functional studies are underway to determine the role of REC8 during
mammalian meiosis. The recently generated Rec8 mutant mouse model exhibited both
male and female infertility. Synaptonemal complex assembly occurred, but it was
formed between sister chromatids rather than between homologous chromosomes (Xu
and McKay, personal communication). These studies indicate that during meiosis, the
“mitotic” cohesion complex members may also have a unique role in spermatogenesis.
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Figure 3: Cell-specific analysis of REC8 expression. (A) A single Rec8 transcript was
detected throughout spermatogenesis. Transcript levels were high in pachytene
spermatocytes, but increased dramatically in post-meiotic round spermatids. (B) A 65kDa band, corresponding to REC8,was first detected in early pachytene spermatocytes.
Expression of the 65-kDa band remained constant throughout spermatogenesis. A lower
45-kDa band was also detected in residual bodies and whole testis extract. Gspermatogonia, L/Z-leptotene/zygotene spermatocytes, EP-early pachytene
spermatocytes, P-pachytene spermatocytes, RS-round spermatids, RB-residual bodies, Twhole testis, XXSxr-whole testis from germ cell-deficient mice.
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Analysis of Meiotic Mutations-H1a, H1t and mei1
Mutant mouse models were analyzed for meiotic defects by immunolocalization of
molecules known to associate with chromosomes in characteristic patterns at various
stages of meiotic prophase (see Part II for more detailed discussion). Antibodies used
included those that recognized the lateral elements of the synaptonemal complex
(SYCP3), DNA double-strand breaks (RAD51, γ-H2AX) and chromosome condensation
(phosphorylated histone H3).

1. H1a-/-, H1t-/- Spermatocytes Show No Impairment in Spermatogenesis
H1a-/-, H1t-/- mutant spermatocytes showed no defects in homologous chromosome
pairing, monitored by localization of SYCP3 (Figure 4). SYCP3 was first observed in
leptotene spermatocytes on the developing lateral elements of the synaptonemal complex.
At pachynema, complete synapsis of the homologous chromosomes was observed,
verified by SYCP1 localization (data not shown). Disassembly of the synaptonemal
complex began in diplonema, and at metaphase I localization was confined to the
centromeres. Identical localization patterns were observed in the heterozygous controls,
demonstrating the linker histones, H1a and H1t, are not necessary for chromosome
pairing and synapsis during meiotic prophase.
Mutant spermatocytes also showed no impairment in the formation and repair of DNA
double-strand breaks (Figure 4 E-H). Leptotene and zygotene spermatocytes from H1a-/-,
H1t-/- mice showed intense localization of γ-H2AX over the entire nuclear area, as also
observed in controls. By pachynema, the localization of γ-H2AX was restricted to the sex
body. The absence of staining over the autosomal chromosomes at pachynema suggests
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Figure 4: Assessment of H1a-/-, H1t-/- spermatocytes for defects in homologous
chromosome pairing and recombination. (A-D) Immunofluorescent co-localization of
SYCP3 (red) and H1t (green) in late pachytene/early diplotene (A and B) and diplotene
(C and D) spermatocytes. Homologous chromosomes were fully synapsed at pachynema,
with no sign of homologous chromosome pairing defects. (E-H) Assessment of
formation and repair of double-strand breaks in H1a, H1t-deficient spermatocytes. In
zygonema (F) γH2AX (green) localized throughout the nucleus, indicative of DNA
double-strand breaks. At pachynema (H), γH2AX localization remained only at the sex
chromosomes, suggesting DNA damage repair was complete. No difference in
localization of γH2AX was detected in heterozygous controls (E and G). The antibody
against the synaptonemal complex protein, SYCP3 (red), was used to identify cell stage.
Scale bar = 10 µm.
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repair of double strand breaks was not impaired in mutant spermatocytes. This was
confirmed by localization of RAD51 (data not shown).
To determine if H1a and H1t were involved in regulating chromosome condensation
at the time of meiotic division, we assessed both the localization of phosphorylated
histone H3 (a marker of division phase chromosome condensation) and the ability of
cultured mutant spermatocytes to respond to OA treatment. The localization of the
phosphorylated form of histone H3 did not differ in pattern or timing between the H1a-/-,
H1t-/- spermatocytes and their heterozygous littermate controls (Figure 5A,D). After OA
treatment, H1a-/-, H1t-/- spermatocytes also condensed chromosomes in an MI
configuration (Figure 5 E,F) with no detectable differences from their heterozygous
littermate controls (Figure 5 B,C). Deficiency of H1t protein in mice null for the H1a,
H1t genes was verified by staining with anti-histone H1t antibody (Figure 4 B,D).
The analysis of H1a, H1t-deficient mice suggest that the linker histones are not
necessary for completion of the events of meiotic prophase or division. The absence of a
phenotype is somewhat surprising since double mutant spermatocytes have a 25%
decrease in the ratio of H1 to nucleosomes. However, microarray analysis of gene
expression also showed that reduced levels of the linker histones did not affect the global
pattern of gene expression (Skoultchi, personal communication), further demonstrating
the linker histones are not essential for the completion of meiosis or spermatogenesis.
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Figure 5: Analysis of chromatin condensation in H1a, H1t-deficient spermatocytes.
Heterozygous (A) and mutant (D) spermatocyte nuclei stained with antiserum against
phosphorylated histone H3 (green) and SYCP3 (red). No difference was observed in the
localization pattern, suggesting mutant spermatocytes have no impairment in
chromosome condensation (B,C and E,F) Assessment of chromosome configuration
after treatment with 5 µM OA. No morphological difference in bivalent MI chromosome
condensation was observed between mutant spermatocytes (E and F) and heterozygous
controls (B and C) after OA treatment. Scale bar = 10 µm.

186

187

2. mei1/mei1 Spermatocytes Arrest Early in Meiotic Prophase Exhibiting Failure of
Homologous Chromosome Synapsis
Meiotic chromosomes from mei1/mei1 spermatocytes exhibited staining of axial
elements with antiserum to SYCP3 (Figure 6 A,B). Partial synapsis of chromosomes was
observed in many mutant nuclei, but full synapsis, indicative of pachynema, was never
observed. The uniform anti-SYCP3 staining along the lengths of chromosomes in the
mutant nuclei suggests that spermatocytes reach a zygotene-like developmental stage and
then arrest.
The RecA homolog RAD51, which is important for meiotic recombination, can be
detected in discrete foci along chromosome cores in normal meioses (Ashley et al., 1995;
Plug et al., 1996; Barlow et al., 1997; Moens et al., 1997). While RAD51 foci were
observed in mei1/+ spermatocytes (Figure 6C), none were detected on chromosome cores
or synapsed chromosomal regions in mei1/mei1 spermatocytes (Figure 6D). Nonetheless,
normal or elevated levels of RAD51 protein could be detected in Western blots of
mei1/mei1 testes (data not shown). Thus, it appears that the protein product of the mei1
gene is required, directly or indirectly, for antigenically recognizable association of
RAD51 with meiotic chromosomes. The absence of this association implies that
recombination in mei1/mei1 spermatocytes may not occur normally or at all.
Phosphorylation of histone H2AX is another marker of DNA double-strand breaks.
To test for the presence of double-strand breaks in mutant spermatocytes, anti-γ-H2AX
antibody was used as a probe. Positive staining of mutant spermatocytes was observed,
consistent with the existence of double-strand breaks (Figure 6 E,F). The data suggest
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Figure 6: Characterization of mei1/mei1 spermatogenic arrest. (A) Normal and (B)
mutant spermatocyte nuclei stained with an antiserum directed against SYCP3, an axial
element component. In the mei1/mei1 nucleus, disorganized and partial pairing of
chromosomes is seen. (C, D) Spermatocyte nuclei co-stained with anti-SYCP3 (red) and
anti-RAD51 (green), where yellow spots are points of colocalization. Numerous foci are
present along mei1/+ zygotene-staged chromosomes (C), but no foci are seen in the
mutant (D). (E) Normal and (F) mutant spermatocyte nuclei co-stained with an
antiserum directed against phosphorylated histone H2AX (green), which is believed to be
an indicator of double-strand breaks, and anti-SYCP3 (red).
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that double-strand breaks occur in mei1/mei1 spermatocytes, but that RAD51 does not
effectively associate with them.
The most notable basis for meiotic failure in mei1/mei1 spermatocytes is a defect in
chromosome synapsis. This synaptic failure may be related to the absence of RAD51
protein foci along meiotic chromosome cores, despite the presence of RAD51 protein in
mutant spermatocytes. In wild-type spermatocytes, RAD51 foci are present from
leptonema through pachynema. It is thought that these foci represent sites where
genetically induced double-strand breaks are repaired by recombination and that RAD51
is a critical constituent of a recombination complex that conducts the repair. The absence
of RAD51 binding suggests that recombination is defective in mei1/mei1 nuclei. Since
mutant spermatocytes stained with γ-H2AX, a marker of chromatin associated with
double-strand breaks, it is possible that recombinational repair of double-strand breaks
may not occur. The failure to repair double-strand breaks, or the absence of
recombination itself, may be responsible for the observed defects in synapsis.
Alternatively, synaptic failure in mei1/mei1 spermatocytes could be explained if MEI1
were required for assembly of other structures ultimately required for synapsis and
recombination, such as the cohesion cores. Assembly of mature synaptonemal
complexes requires interaction of several proteins, and it is likely that not all of these
have been identified.

Conclusion
Taken together these experiments provide additional insight into the proteins needed
for chromosomal remodeling during spermatogenesis. These studies, in conjunction with
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the results of other labs, have implicated “mitotic” specific proteins in regulating meiotic
cohesion, suggesting that regulation of cohesion in mammalian systems is more complex
than in lower eukaryotes. Functional studies currently underway will help to clarify and
define the role(s) of these proteins in regulating/maintaining meiotic cohesion.
Although mutational analyses are essential for determining gene function, they do not
always provide answers to protein function. An example of this, generation of H1a, H1tdeficient spermatocytes, is presented here. The double mutant mice had no obvious
impairment in spermatogenesis, and thus protein function has not been elucidated.
As an alternate to using knockout technology to determine gene function, mutagenesis
studies have been initiated to identify novel genes and gene function. mei1 is an example
of a novel meiotic mutation identified through a mutagenesis screen. Characterization of
the mei1 mutation demonstrates the importance of these studies to identify new players
regulating meiosis in higher eukaryotes.
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CHAPTER I
SUMMARY

Much of what is known about the regulation of meiosis has come from analysis of
oocytes. Although the overall goal of meiotic division, the production of haploid
gametes, is conserved between males and females, evidence from both developmental
and genetic studies indicates that regulation of the meiotic divisions is not necessarily
conserved. Generation of mutant mouse models has made this evident, as many mutations
(Spo11, Sycp3, γ-H2ax, Cdc25B) cause sexually dimorphic phenotypes (for review see
Cooke and Saunders, 2002; Matzuk and Lamb, 2002). The primary goal of this
dissertation was to provide insight into the timing and regulation of events surrounding
meiotic division in the male. A variety of different experimental approaches were taken
to accomplish this goal, including immunolocalization studies, treatment of isolated
pachytene spermatocytes with chemical inhibitors, and analysis of meiotic mutations.
Although we are still far from understanding the events and regulation of male meiosis,
we have come a little closer. This final part, Part V, summarizes what we have learned
and addresses the next steps to be taken.

Establishing the Order of Events-Creation of a Meiotic Timeline
In order to understand why errors arise during meiosis, we must first understand how
events unfold normally. Specifically, we need to know what events occur, the order in
which they occur, and how the processes are interrelated. In Part II, we analyzed protein
expression and localization as a way to determine temporal order, these studies resulted
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in the production of the meiotic “timeline” (Figure 1). Establishment of the meiotic
timeline, along with generation of meiotic mutants, has proven useful. It has enabled us,
as well as others, to determine that recombination precedes and is necessary for
homologous chromosome synapsis (Baudat et al., 2000; Romanienko and CameriniOtero, 2000; Yuan et al., 2000; Mahadevaiah et al., 2001; Celeste et al., 2002),
suggesting that in mammals the regulation of recombination and homologous synapsis
mirrors that observed in the yeast Saccharomyces cerevisiae (Padmore et al., 1991).
The establishment of the timeline has also allowed us to identify potential players in
the G2/MI transition during spermatogenesis. Immunolocalization of the checkpoint
proteins, CENP-E, CENP-F, and XMAD2, puts them at the right place and time for
acting in a spindle assembly checkpoint during spermatogenesis (Figures 8 and 9, Part
II), supported recently by analysis of mice containing Robertsonian translocations (Eaker
et al., 2001). Immunolocalization analysis places the MAPKs at the meiotic spindle in
metaphase I (Figure 3, Part III), implicating them in a conserved role in spindle assembly
and/or maintenance, similar to mitotic cells and meiotically dividing oocytes (Gotoh et
al., 1991; Verlhac et al., 1993; Araki et al., 1996; Verlhac et al., 1996; Guadagno and
Ferrell, 1998; Gordo et al., 2001; Horne and Guadagno, 2003).
Perhaps most importantly the timeline is a valuable reference for analysis of meiotic
mutations. In Part IV, mutant mouse models were analyzed for meiotic abnormalities, as
a means to determine gene function, by comparing the localization patterns observed in
mutant spermatocytes to localization patterns documented in the timeline. Analysis of
H1a, H1t-deficient spermatocytes revealed no meiotic prophase or division phase effects
(Figures 4 and 5, Part IV), demonstrating the linker histone H1a and the testis-specific
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Figure 1: Timeline representation of protein localization and expression throughout
meiosis in mouse spermatocytes. Black-solid arrow = determined by
immunolocalization; Black-dashed arrow = determined by Western analysis.
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histone H1t are not necessary for the events of meiotic prophase and the division phase.
Immunolocalization and expression studies conducted on mei1 mice, identified in a
mutagenesis screen, enabled us to characterize a new meiotic mutation. mei1/mei1
spermatocytes fail to synapse homologous chromosomes, arresting at a zygotene-like
state, determined by the localization pattern of SYCP3, a synaptonemal complex protein
(Figure 6B, Part IV). This phenotype, which is in some respects similar to that of Spo11deficient spermatocytes (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000),
suggests that deficiency for MEI1 causes defects in recombination or in repair of doublestrand breaks. Immunolocalization analysis revealed that RAD51, a marker for doublestrand breaks, failed to localize in mei1/mei1 spermatocytes (Figure 6D, Part IV),
although the RAD51 protein was present, detected by Western blot analysis. This
observation, coupled with the positive immunoreactivity observed in the mutant
spermatocytes upon localization of γ-H2AX, a marker for double-strand breaks, suggests
that MEI1 is not needed for initiation of DNA double-strand breaks, but instead may be
necessary in recruiting repair factors to the sites of damage (Figure 6F, Part IV).
The timeline is a valuable reference tool to which we can compare and characterize
future mutant mouse models. Although many of the defining events of meiosis, such as
recombination and homologous chromosome pairing, have been documented in this study
this is a project without a fixed endpoint. As new genes/proteins are identified they will
be added, increasing our knowledge of the timing and interdependence of events. These
studies will continue to increase our understanding of meiosis and provide additional
insights into the regulation of meiotic processes in the male.
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Investigation of the Players Involved in the OA-Induced Meiotic G2/MI Transition
The development of a short-term culture system has facilitated the analysis of the
meiotic G2/MI transition during spermatogenesis (Handel et al., 1995; Wiltshire et al.,
1995), but has raised questions as to how closely this artificial state mimics the naturally
occurring transition. Are the same regulatory molecules involved as in the natural
progression? Are all spermatocytes able respond to OA treatment or are certain factors
needed for a response?
Results from previous studies seeking answers to these questions identified MPF as an
essential component in regulating OA-induced chromosome condensation (Cobb et al.,
1999b). These studies also implicated the CDC25C protein phosphatase as a likely
candidate for regulating MPF activation (Cobb et al., 1999a). The generation of a fertile
Cdc25C-deficient mouse model (Chen et al., 2001) allowed us to directly test the role(s)
of CDC25C in regulating these processes. In contrast to what had been surmised, our
analysis indicates that the CDC25C protein phosphatase is not an essential regulator of
the artificially OA-induced transition. Mutant spermatocytes responded to OA treatment
by condensing bivalent MI chromosomes and activating MPF at levels comparable to
their heterozygous littermate controls (Figures 15 and 16, Part III). These experiments
also suggest that the in vitro transition is similar to the in vivo transition, as CDC25C is
not required for either.
Although these experiments provided insight into what regulatory molecules are not
needed for the OA-induced transition (Figure 2), the question still remains as to what is
required. Another Cdc25 family member, CDC25A, is a possible candidate; expression
analysis has shown that it is present in diplotene spermatocytes (Mizoguchi and Kim,
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Figure 2: Revised model of MPF activation. CDC25C is not needed for MPF activation
in mouse spermatocytes, demonstrating that another protein phosphatase, activated upon
OA treatment, is responsible for MPF regulation. A possible candidate is the CDC25A
protein phosphatase.
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1997), putting it at the right place and time for acting in the G2/MI transition. However,
functional studies are still needed to confirm its role(s) in the transition.

MPF Activation of the MAPKs - Evidence for a Novel Regulatory Pathway
The MAPKs have previously been implicated in regulating aspects of chromosome
condensation induced by OA treatment (Sette et al., 1999; Di Agostino et al., 2002).
Studies reported in this dissertation also suggest that the MAPKs play a role in
chromosome condensation at the G2/MI transition. However, in contrast to earlier work
our experiments suggest a novel mechanism controlling MAPK activation.
The MAPKs are activated in response to OA treatment (Figure 7, Part III), implicating
them as regulators in the spermatocyte’s G2/MI transition. In both mitotically dividing
cells and in meiotically dividing oocytes, the MAPK kinases, MEK1/2, are responsible
for activation of the MAPKs, ERK1/2. In oocytes, the MAPK kinase kinase MOS is also
a requirement for ERK1/2 activation. However, analysis of Mos-deficient spermatocytes
and treatment of pachytene spermatocytes with the MEK1/2 inhibitor, U0126, revealed
that surprisingly, these molecules are not required for MAPK activation in spermatocytes.
Mos-deficient spermatocytes activated the MAPKs and condensed bivalent MI
chromosomes in response to OA at levels similar to controls (Figure 14, Part III), while
U0126 treatment did not inhibit MAPK activity or block chromosome condensation
(Figure 8, Part III). Instead inhibition of MAPK activation and chromosome
condensation was observed only after treatment with butyrolactone I, an inhibitor of MPF
(Figures 11 and 12, Part III).
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Regulation of MAPK activity by MPF is not novel; however, the manner in which this
regulation occurs in the spermatocyte may be. A previous report demonstrated that in rat
oocytes MPF controlled MAPK activation by stabilizing the Mos transcript (Josefsberg et
al., 2003). However, our analysis of Mos-deficient spermatocytes shows no impairment
in spermatogenesis or MAPK activity, demonstrating that this pathway is not conserved.
Taken together these results suggest that MPF may directly interact with the MAPKs
and/or controls the regulation of an unidentified regulatory molecule that influences the
activation state of the MAPKs (Figure 3).

Conclusion
It has been nearly 30 years since Wasserman and Masui (1976) initially characterized
MPF, and yet today we still have not unraveled precisely how it is activated or what
factors govern its activation. From work presented here we know that CDC25C is not
required by the spermatocyte for activation of its MPF, leaving us asking what is required
in spermatocytes. Currently, our laboratory is in the initial stages of “phosphataseprofiling,” trying to identify potential regulators of MPF by looking at expression
profiles, putting them at the right time and place for regulating the meiotic G2/MI
transition. A likely candidate that has emerged is CDC25A, however, to date there is no
mutant mouse model or chemical inhibitor to directly test its role.
Additionally, studies are needed to define more precisely how spermatocyte MPF
regulates MAPK activation, specifically if this is a result of a direct or indirect
interaction. Immunoprecipitation studies could be useful way to test this interaction. It
is possible that a testis-specific regulatory molecule may be involved, explaining the
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Figure 3: Proposed model for MAPK activation at the G2/MI transition in mouse
spermatocytes. Activation of the MAPKs, ERK1/2, at the meiotic G2/MI transition is not
dependent upon MOS or the ERK1/2-activating kinases, MEK1/2. However, activity is
dependent upon MPF, suggesting that spermatocytes have a novel mechanism for MAPK
activation.
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difference in regulation between males and females. These speculations and guesses
underscore the importance of on-going mutagenesis screens to identify new
genes/proteins that affect meiotic division in both males and females.
Results from experiments using the MEK1/2 inhibitor, U0126, also raise the issue of
why the regulation of MAPK activity in the mitotic spermatogonia and early meiotic
prophase spermatocytes differs from that in spermatocytes undergoing the G2/MI
transition. Could this be due to OA abrogation of normal regulatory events? This leads
us back to the important question of how faithfully this artificial OA-induced transition
mimics the natural transition.
The investigation of the events and players regulating the meiotic G2/MI transition
during spermatogenesis is clearly still in its early stages. Experiments presented in this
dissertation, however, provide the groundwork for future experiments to further explore
the sexual dimorphism that exists in the regulation of male and female meiosis. Solving
these issues will lead not only to better understanding of meiosis but also of
spermatogenesis and gametogenesis in general.
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